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Abstract
As femoral access percutaneous cardiac interventions (PCIs) increase in the United States, so
will vascular complications. Nurses play a vital role in increasing comfort and decreasing
vascular complications in patients who have undergone a femoral access PCI, through
monitoring and early ambulation. Early ambulation is supported by the literature, yet a sacred
cow of nursing, prolonged bed rest, continues in clinical practice with varied nursing perception
of optimal early ambulation time. The purpose of this integrative review was to assess if nursing
perception of optimal ambulation time after a femoral access PCI, four hours, has any impact on
vascular complications in adult patients. The 15 articles reviewed showed that low-risk patients
are eligible for early ambulation at four hours or less post-femoral access PCI and nurses should
consider a patient’s history and risk factors prior to ambulating the patient. Other themes include
lack of evidence from clinical practice guidelines (CPGs), varying definitions of low-risk
patients and variables, methodological study flaws, lack of evidence linking risk factors and
early ambulation, and nursing need for early ambulation education. Wagner’s Chronic Care
Model’s elements of decision support and clinical information systems were used to guide the
nursing implications and recommendations. Decision support systems such as evidence-based
CPGs, are needed for post-PCI nursing care in the United States. Clinical information systems
such as the electronic health record, can help guide and support post-PCI nursing care in the
form of flow sheets, clinical decision tools, and clinical pathways. Additional nursing
implications and recommendations include nursing education based on the latest evidence-based
literature, standardizing variable definitions, and a call for an additional randomized control trial
to correlate risk factors and early ambulation after a femoral access PCI.
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Introduction
Introduction to Inquiry
The primary purpose of this integrative review is to assess if early ambulation at four
hours or less has an effect on vascular complications after a femoral access percutaneous cardiac
intervention (PCI). This section will cover the background of the problem, a global
understanding of the PCI process, rationale of inquiry, the clinical question posed in PICO
format (Gray, Grove, & Sutherland, 2017), and the method of inquiry. A global understanding of
the PCI includes understanding what a PCI is, indications for the procedure, adjunctive therapies,
the PCI process, and vascular risk factors and complications (Abdollahi, Mehranfard,
Behnampour, & Kordnejad, 2015; Benjamin et al., 2019; Davis & Shiel, 2019; Kern, Sorajja, &
Lim, 2016; Levine et al., 2011; Mann, Zipes, Libby, Bonow, & Braunwald, 2019; Sajnani &
Bogart, 2013; Sandoval et al., 2017; Schiks et al., 2008; Stouffer & Peter, 2016; Upvall,
Vougault, Pigon, & Swartzman, 2019; Wentworth et al., 2018; Woods, Froelicher, Motzer, &
Bridges, 2010).
Background
Every forty seconds, an American will suffer from a myocardial infarction (MI;
Benjamin et al., 2019), which is an indication for a PCI, or a non-surgical cardiac procedure
(Stouffer & Peter, 2016). In 2018, the number of PCIs performed was “more than 950,000 per
year and rising” (Kim & Zamanian, 2018, para. 4) within the United States (U.S.). The
hospitalization cost for a MI often includes a PCI, which is usually the most expensive part of the
hospital experience for a patient with a MI. The cost of a PCI without complications in the U.S.
averages around $18,931. Vascular complications, which are reported in 1.4% of patients
undergoing a PCI (Benjamin et al., 2019), can lead to an additional cost of $2,026 to the hospital
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bill (Cowper et al., 2019). Nurses play an important role in the recovery and outcomes of the
patients, especially during the post-procedural period when many vascular complications can
arise (Rolley, Davidson, Salamonson, Fernandez, & Dennison, 2009; Rolley, Salamonson,
Wensley, Dennison, & Davidson, 2011). Cowper et al. (2019), estimate that 20% of the cost of a
PCI is allocated for post-procedure care, making the role of the nurse essential in ensuring
optimal outcomes for patients undergoing a PCI (Rolley et al., 2009; Rolley et al., 2011).
Clinical nurses are responsible for pulling the introducer sheath, assessing for vascular
complications while a patient is on bed rest, and safely ambulating the patient (Rolley et al.,
2009; Rolley et al., 2011). A patient who has had a femoral access PCI must be maintained on
bed rest for several hours to maintain hemostatis and prevent vascular complications (Abdollahi
et al., 2015). This prolonged bed rest can cause back pain, urinary retention, and patient
dissatisfaction (Augustin, Quadros, & Samento-Leite, 2010; Mohammady et al., 2013; Schiks et
al., 2008). Despite an uptick in literature addressing and advocating for early ambulation postfemoral PCI to decrease these side effects and promote same day discharge, nurses continue to
practice prolonged bed rest in order to prevent vascular complications (Augustin et al., 2010;
Kim et al., 2013; Rolley, Davidson, Salamonson, Dennison, & Davidson, 2010; Schiks et al.,
2008). Prolonged bed rest after a PCI, like many nursing actions, are not based in evidence, but
on experimental care (Abdollahi et al., 2015). This type of practice can be viewed as a sacred
cow of the nursing practice (Upvall et al., 2019). Sacred cows are “old habits in practice,
considered routine and above dispute regardless of evidence to the contrary” (Hanrahan et al.,
2015, p. 3). These sacred cows are tightly woven into clinical practice and often not based in
evidence, but on tradition (Upvall et al., 2019).
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The research and implementation of evidence-based nursing cares has not evolved as
quickly as medical aspects of the PCIs. Medical aspects of the PCI procedure have evolved
rapidly and include advances in adjunctive therapies, technologies, and procedural techniques
(Matte, de Souza Hilário, Reich, Aliti, & Rabelo-Silva, 2016; Schiks et al., 2008). One possible
explanation may be that “vascular sheath removal, mobilization, and ambulation protocols vary
according to the device protocol and hospital policy” (Moser & Riegel, 2008, p. 543). There is
also little evidence to support early ambulation post-femoral PCI in the U.S. from clinical
practice guidelines (CPGs) that minimize vascular complications (Levine et al., 2011; Rolley et
al., 2010; Rolley et al., 2011).
Nurses not only play a vital role in ensuring comfort after a PCI, their ability to assess for
vascular complications and ambulate patients safely could have financial implications for the
hospital system (Augustin et al., 2010; Cowper et al., 2019). To debunk this sacred cow of
nursing practice, a global understanding of the femoral PCI procedure, indications for a PCI,
adjunctive therapies, vascular risk factors and complications must be addressed—and it must be
done prior to promoting the evolution of evidence-based nursing interventions such as early
ambulation post-femoral PCI (Abdollahi et al., 2015; Benjamin et al., 2019; Davis & Shiel,
2019; Kern et al., 2016; Levine et al., 2011; Mann et al., 2019; Sajnani & Bogart, 2013;
Sandoval et al., 2017; Schiks et al., 2008; Stouffer & Peter, 2016; Upvall et al., 2019; Wentworth
et al., 2018; Woods, Froelicher, Motzer, & Bridges, 2010).
PCI Definition and Indications. PCI is a term that encompasses several interventional
procedures in the coronary arteries with a percutaneous approach (Woods et al., 2010). It
includes procedures undertaken after the diagnostic coronary angiogram (Kern et al., 2016), and
could include coronary artery stent placement, balloon angioplasty, or atherectomy (Wentworth
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et al., 2018; Woods et al., 2010). Clinical indications for PCIs include acute ST-elevation MI,
non-ST-elevation MI, high-risk stress test results, unstable angina, and anginal symptoms
equivalents (Stouffer & Peter, 2016).
Femoral access in PCIs is the most popular access point for PCIs—accounting for 74.5%
of all PCIs—in the U.S. catherization labs, despite an increase in radial access within the last
several years (Benjamin et al., 2019; Mann et al., 2019; Stouffer & Peter, 2016). Implications for
a femoral access PCI over a radial access PCI include coronary chronic total occlusion PCIs,
cases needing mechanical circulatory support devices for cardiogenic shock, cardiac arrest
(Sandoval et al., 2017), and in contraindications to radial access such as subclavian abnormalities
(Kern et al., 2016). Benjamin et al. (2019) reports that the risk of vascular injury post-procedure
is approximately 1.4%. This complication rate may have declined from earlier PCI approaches
due to advances in drug regimes, decreased sheath size, procedural enhancements, increased
interventionists knowledge, and advancement in procedural equipment such as the vascular
closure device (Moser & Riegel, 2008; Woods et al., 2010). This number may seem small,
however if 950,000 PCIs were completed in 2018, this would mean there was around 13,300
related vascular events that year and potentially an increased cost of around $27 million dollars
(Kim & Zamanian, 2018).
PCI Adjunctive Therapies and Process. Prior to any type of PCI, dual oral antiplatelet
therapy should be given. This includes an aspirin (81-325 milligrams) and a P2Y12 platelet
inhibitor (Levine et al., 201l; Stouffer & Peter, 2016), and should be continued after the
procedure based on guideline-based timeframes (Levine et al., 2011). These drugs work to lower
factors that increase platelet aggregation, stent thrombosis, and are recommended for all patients
with a stent (Stouffer & Peter, 2016). After access has been obtained in the femoral artery,
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catheter-based coronary angiography begins, or obtaining coronary, ventricular, and peripheral
vascular images. Coronary angiography is the gold standard for diagnosing coronary artery
disease and visualizing lesions for intervention (Kern et al., 2016).
Once appropriate imaging and data gathering is complete within a coronary angiogram,
intravenous (IV) anticoagulants, antiplatelets, or direct thrombin inhibitor agents are usually
given (usually if dual antiplatelet therapy was not given during the pre-procedure time period)
prior to guidewire insertion (Stouffer & Peter, 2016). These IV agents work to decrease adverse
events of the invasive procedure such as ischemia and thrombus formation at the arterial site of
injury, on the catheters, and on the guidewires (Levine et al., 2011). A guidewire is then
introduced over the stenotic coronary artery lesion, with possible vessel preparation with a semicompliant balloon or an atherectomy device. Finally, the stent of choice is passed over the
guidewire and deployed (Stouffer & Peter, 2016). Whether a vascular compression device,
manual compression, or another compression device such as the FemoStop™, has been used to
maintain hemostatis the femoral access site, careful monitoring for vascular complications
should occur to assess for potential vascular complications from the puncture site and
surrounding area (Kern et al., 2016). Bed rest is then started to maintain hemostasis with duration
dependent on hospital policy and device protocol (Moser & Riegel, 2008).
Vascular Risk Factors. The at-risk groups for vascular complications include female
gender, low body weight, advanced age, use of anticoagulants medications, use of antiplatelet
medications such as glycoprotein (GP) IIb/IIIa inhibitors, large catheter size as defined by
provider, length of time catheter is in place, peripheral vascular disease, diabetes mellitus,
hypertension, renal dysfunction, and urgent invention (Merriweather & Sulzbach-Hoke, 2012;
Moser & Riegel, 2008; Woods et al., 2010). Females are at a higher risk for two reasons. First,
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females tend to have common femoral arteries that are shorter in length and smaller in diameter
than their male counterparts. Second, post-menopausal women are usually PCI candidates. A
post-menopausal woman’s lack of estrogen has a negative effect on function, integrity, and
arterial structure and can also contribute to bleeding. Patients with low body weight have smaller
femoral artery diameters, with similar access issues to women (Sajnani & Bogart, 2013).
Obese patients, despite having more cardiovascular risk factors, have a decreased
vascular complication risk. This population tends to be younger, and have increased platelet
aggregation and fibrinolysis related to obesity. Patients with advanced age are at risk for vascular
complications related to advanced vascular disease and possible local vascular changes. Patients
with hypertension are at an increased risk of bleeding when the femoral sheath is removed.
Patients with renal dysfunction are a high risk for vascular complications related to their reduced
renal excretion of antiplatelets and anticoagulants such as GP IIb/IIIa inhibitors and
unfractionated heparin (Merriweather & Sulzbach-Hoke, 2012). Diabetics are also at risk for
vascular complications related to renal dysfunction post-PCI and a pathophysiological response
to arterial injury that leads to poor outcomes post-PCI (Malviya & Mishra, 2015).
Vascular Complications. There has been a recent trend within the medical world to
define bleeding events for consistent research definitions, as many definitions have emerged
within academic studies (Singh, 2015; Subherwal et al., 2012). Within the literature, the terms
vascular, bleeding, and puncture site complications, are used interchangeably to describe
vascular events from slight oozing of blood at the puncture site, hematomas, retroperitoneum
hematomas, arterial venous (AV) fistulas, and pseudoaneurysms. The terms vascular events, or
vascular complications, will be used to define the previously listed events found in the literature
within this review (Antonsen, Jensen, & Thayssen, 2013; Augustin et al., 2010; Benjamin et al.,
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2019; Cowper et al., 2019; Kern et al., 2016; Kim & Zamanian, 2018; Koch et al., 1997; Koch et
al., 1999; Kobrossi, Tamim, & Dakik, 2014; Levine et al., 2011; Kim et al., 2013; Merriweather
& Sulzbach-Hoke, 2012; Mohammady et al., 2013; Moser & Riegel, 2008; Rolley et al., 2009;
Rolley et al., 2010; Rolley et al, 2011; Schiks et al., 2008; Singh, 2015; Stouffer & Peter, 2016;
Subherwal et al., 2012; Tongsai & Thamlikikul, 2012; Walker, Jen, McCosker, & Cleary, 2008;
Wentworth et al., 2018; Wood et al., 2010). Clinicians can use the National Cardiac Data
Registry (NCDR) database to calculate PCI bleeding risk (Singh, 2015). The NCDR keeps data
within the Cath PCI database and defines major bleeding in three categories: bleeding requiring
hospitalization or blood transfusion, a decrease in hemoglobin greater than 3.0 g/dL, and
percutaneous entry site hematomas with a major femoral access site bleed or hematoma
measured at greater than 10 cm (Subherwal et al., 2012). As these definitions are in the medical
context and do not incorporate all the vascular issues experienced by the clinical nurse, both
minor and major, the definitions are pulled from a nursing academic textbook that are usually
used by nurses and taught by cardiovascular nursing experts in Woods et al. (2010) and Moser
and Riegel (2008).
There are several types of vascular complications after a PCI that can occur from one to
12 hours after a procedure. Since there is a large span of hours considered as complication time,
there is a lack of reporting, which may have led to the lack of evidence and thus few clinical
practice changes in post-PCI since the 1980s (Moser & Riegel, 2008). These vascular
complications include slight oozing of external blood, hematomas, retroperitoneal hematomas,
pseudoaneurysms, arteriovenous (AV) fistulas, and peripheral arterial occlusions (Moser &
Riegel, 2008; Woods et al., 2010). Although peripheral arterial occlusions are considered a
complication within Moser & Riegel’s (2008) interpretation of post-femoral access PCI
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complications, no evidence-based studies considered this a complication or recorded instances of
peripheral arterial occlusions, and thus it was left out of the definition of vascular events within
this paper (Antonsen et al., 2013; Augustin et al., 2010; Koch et al., 1997; Koch et al., 1999;
Kobrossi et al., 2014; Levine et al., 2011; Kim et al., 2013; Mohammady et al., 2013; Rolley et
al., 2009; Rolley et al., 2010; Rolley et al, 2011; Schiks et al., 2008; Tongsai & Thamlikikul,
2012; Walker et al., 2008; Wentworth et al., 2018).
External Bleeding. Visible blood loss at the puncture site is Moser and Riegel’s (2008)
definition of external bleeding. This is the easiest vascular complication to recognize and
management includes manual pressure or placing a femoral compression device (Moser &
Riegel, 2008).
Hematomas. A hematoma is a collection of usually clotted blood that has leaked out into
the tissues and can be from a venous, arterial, or capillary source (Davis & Shiel, 2019; Moser &
Riegel, 2008). Symptoms of a localized hematoma include: pain, redness, and swelling (Davis &
Shiel, 2019). Management of a hematoma varies depending on the size, from comfort measures
and applying direct pressure. The literature has varying definitions of hematoma size, with
varying times for intervention (Davis & Shiel, 2019; Moser & Riegel, 2008; Woods et al., 2010).
Retroperitoneal hematomas. A retroperitoneal hematoma is a hematoma that is caused by
blood leaking into the retroperitoneum space and can result from puncturing above the inguinal
ligament with arterial sheath placement. Symptoms include groin and lumber area pain,
hypotension, drops in hematocrit, and tachycardia. Diagnosis is by computed tomography and
management involves fluid resuscitation, possible transfusion of blood products, and possible
surgical repair of the affected artery (Woods et al., 2010).
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Pseudoaneurysms. A pseudoaneurysm is defined by Woods et al. (2010) as an
“extraluminal cavity in communication with an adjacent artery, usually the femoral artery and
vein, which results in a false communication” (p. 546). Signs and symptoms include a pulsating
mass in the groin, systolic bruit, and pain in the groin with normal distal arterial pulses. Color
flow imaging and doppler ultrasound are used to confirm. Small pseudoaneurysms usually close
in four to eight weeks spontaneously, but if they increase in size and hemorrhage, the patients
will be on long-term anticoagulation. Management includes surgical closure, ultrasound guided
compression, or ultrasound guided thrombin injections (Woods et al., 2010).
AV Fistula. An AV fistula is defined as a channel or communication between a vein and an
artery and involves both puncture of the vein and the artery resulting in a false communication
between the two. Signs and symptoms include groin mass with pulsation, decreased temperature
of the extremity, continuous systolic-diastolic bruit increasing over time, positive thrill at the
site, and possible ischemia of the extremity. Color flow imaging and doppler ultrasound are used
to confirm. Management includes surgical repair (Woods et al., 2010).
Purpose of Inquiry
Despite the ever-changing landscape of the PCI, bed rest is still necessary after pulling
the femoral sheath to maintain hemostasis and prevent vascular complications related to the
trauma of the invasive sheath (Abdollahi et al., 2015). The increased risk for vascular
complications stems from the adjunct medical therapies of anticoagulants, antiplatelets, and
direct thrombin inhibitor medications (Moser & Riegel, 2008; Stouffer & Peter, 2016). Moser
and Riegel (2008) summarize that patients who were traditionally kept on bed rest after a
femoral access PCI for up to six hours experienced “aggravated preexisting musculoskeletal
disorders” (p. 246). Other side effects were prolonged patient dissatisfaction and urinary
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retention (Augustin et al., 2010). Nursing interventions often look to increase patient comfort and
satisfaction, while preventing complications. Early ambulation has been shown in studies over
the past two decades to decrease these negative patient outcomes and sometimes lead to same
day discharges (Moser & Riegel, 2008; Schiks et al., 2008).
Despite the increase in supportive literature surrounding early ambulation post-femoral
PCI, traditional practices such prolonged bed rest to prevent vascular complications continue
within clinical practice (Kim et al., 2013; Rolley et al. 2010; Schiks et al. 2008; Upvall et al.,
2019). This may be due to a lack of “established evidence-based standard” (Kim et al., 2013, p.
430) within hospital systems (Kim et al., 2013; Woods et al., 2010). The confusion on optimal
ambulation time post-PCI is evident in the survey conducted by Rolley et al. (2010) of Australian
and New Zealand cardiovascular nurses on their lived experiences of not only providing PCI
cares, but the difference between this experience and the literature. The nurses’ responses to the
question of optimal early ambulation after a femoral access PCI varied from less than one hour to
greater than eight hours, with nearly half of the nurses selecting four hours (Rolley et al., 2010).
This finding is in contrast to the literature which notes ambulation after PCIs ranges from two to
24 hours (Mohammady et al., 2013). This paper seeks to answer if the perception within nursing
clinical practice, ambulation after four hours of bed rest or less, is supported in the literature and
to assess if this perception of early ambulation at four hours or less post-PCI has any impact on
vascular complications (Rolley et al., 2010).
Research Question
The research question presented in PICO format (Gray et al., 2017), is as follows: (P) In
adult patients undergoing PCI with a femoral access, (I) does early ambulation at or less than
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four hours post-procedure, (C) as compared to later ambulation greater than four hours, (O) have
any impact on a patient’s risk of vascular complications?
Method of Inquiry
An integrative review will be used to assess if early ambulation post-PCI has any impact
on a patient’s risk of vascular complications. According to Whittemore and Knafl (2005), “an
integrative review is a specific review method that summarizes past empirical or theoretical
literature to provide a more comprehensive understanding of a particular phenomenon or
healthcare problem” (para. 1). The integrative review also allows for different review methods,
such as experimental and non-experimental, to be combined together in order to have a full
understanding of the issue in question. This type of review allows for a broad range of purposes
from exploring theories, concept definition, researching methodological issues, and reviewing
the evidence on a topic. An integrative review was used for this paper to explore the evidence
behind vascular complication after early ambulation at or less than four hours post-femoral PCI
(Whittemore & Knafl, 2005). Nursing implications and recommendations are then presented and
guided by parts of Wagner’s Chronic Care Model (CCM; Rolley et al., 2009; Wagner, Austin, &
Von Korff, 1996a; Wagner et al., 2001).
Literature Review
Introduction to Literature Review
This section of the integrative review covers the search strategy used (see Appendix A),
methods (see Appendix B), appraisal and synthesis, and a conclusion summarizing the seven
themes found within the literature table (see Appendix C). An in-depth analysis of the three
meta-analyses and the two evidence-based CPGs can be found in Appendices D, E, F, G, and H.
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Search Strategy
A thorough literature search was conducted, resulting in 15 articles pertaining to early
ambulation, decreased time in bed, and addressing how these variables had an effect on vascular
complications in patients undergoing a post-femoral PCI. As seen in Appendix A, Cochrane,
CINAHL, ProQuest Nursing & Allied Health Databases, Ovid, PubMed, and the American
College of Cardiology guideline databases were searched. References of all articles that were
reviewed were searched; and within CINHAL, articles that used reviewed articles as references
were also assessed. Keywords used to find relevant articles include cardiac catherization,
percutaneous coronary intervention, PCI, coronary angiography, percutaneous transluminal
coronary angioplasty, angioplasty, early ambulation, early mobility, early mobilization, femoral,
femoral access immobilization, bed rest, guidelines, protocols, practice guidelines, clinical
practice guidelines, adverse effects, side effects, negative effects, complication, nursing, and
John X. Rolley. John X. Rolley was used as a keyword as he is an Australian professor who has
co-authored three of the 15 articles selected. Subject headings used also find relevant articles
include angioplasty, transluminal percutaneous coronary, and ambulation. Other keywords and
subject terms can be found in Appendix A.
Seven articles that were originally chosen that were published after 2009 were ruled out
because the study’s population consisted of patients who underwent diagnostic coronary
angiogram and did not include any patients undergoing a PCI (see Appendix A). This is relevant
because if an intervention, or a PCI, is deemed necessary after the diagnostic coronary
angiogram is complete, IV anticoagulants, antiplatelet, and direct thrombin inhibitor medications
are given. These drugs decrease adverse events such as ischemia and thrombus formation at the
arterial site of injury, on the catheter, and on the guidewires (Levine et al., 2011; Stouffer &
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Peter, 2016). Use of anticoagulants, antiplatelet, and direct thrombin inhibitor medications can
increase a patient’s risk for vascular complications post-PCI by delaying clot formation (Moser
& Riegel, 2008; Woods et al., 2010). The 15 chosen articles included either PCI or a mixture of
PCI and coronary diagnostic angiogram patients (Antonsen et al., 2013; Augustin et al., 2010;
Koch et al., 1997; Koch et al., 1999; Kobrossi et al., 2014; Levine et al., 2011; Kim et al., 2013;
Mohammady et al., 2013; Rolley et al., 2009; Rolley et al., 2010; Rolley et al., 2011; Schiks et
al., 2008; Tongsai & Thamlikikul, 2012; Walker et al., 2008; Wentworth et al., 2018).
Methods
The articles chosen to assess the research question incorporated varying types of research
methods and had varying levels of evidence (LOE), as scored using Ackley, Swan, Ladwig, and
Tucker’s (2008) Levels of Evidence in Nursing Research (see Appendix B). The 15 selected
articles reviewed can be found in the literature tables (see Appendix C), and include three metaanalyses (Level I; Kim et al., 2013; Mohammady et al., 2013; Tongsai & Thamlikikul, 2012),
two evidence-based CPGs for PCI (Level I; Levine et al., 2011; Rolley et al., 2011), one
randomized control trial (RCT; Level II; Augustin et al., 2010), three quasi-experimental studies
(Level III; Koch et al., 1997; Koch et al., 1999; Walker et al., 2008), one prospective nonrandomized comparative study (Level III; Schiks et al., 2008), one survey (Level VI; Rolley et
al., 2010), one retrospective cohort study (Level IV; Antonsen et al., 2013), one retrospective
observational study (Level IV; Kobrossi et al., 2014), one retrospective case study (Level IV;
Wentworth et al., 2018), and one systematic integrative literature review (Level V; Rolley et al.,
2009).
Two tools helped further assess the meta-analyses and evidence-based CPGs. DiCenso,
Guyatt, and Ciliska’s (2005) Meta-Analysis Tool, guided the review of the meta-analyses of Kim

14
et al. (2013; see Appendix D), Mohammady et al. (2013; see Appendix E), and Tongsai &
Thamlikikul (2012; see Appendix F). The evidence-based CPGs of Levine et al. (2011; see
Appendix G), and Rolley et al. (2011; see Appendix H), was guided by the Advancing Guideline
Development, Reporting, and Evaluation in Healthcare [AGREE II] tool (Brouwers et al., 2010).
Appraisal and Synthesis
Introduction. The PCI procedure has rapidly evolved from a medical standpoint, yet
nursing care related to decreasing bed rest or time in bed, and early ambulation has failed to
evolve at the same pace since the first cardiac interventional procedure was performed by
Andreas Gruentzig in 1977 (Woods et al., 2010). There is no consensus in the U.S. for cardiac
bed rest protocols and early ambulation after a femoral sheath PCI from either the nursing or
medical academic textbooks (Kern et al., 2016; Mann et al., 2019; Moser & Riegel, 2008; Woods
et al., 2010). In one academic medical textbook, Mann et al. (2019) recommends patients who
are undergoing femoral access PCIs require two hours of bed rest if they had a four to six French
introducer catheter, and three to four hours for a six French or higher introducer catheter.
However, in clinical practice, ambulation varies according to the hospital policy or device
protocol (Mann et al., 2019).
In nursing academic textbooks, Moser and Riegel’s (2008) state that “removal of femoral
sheaths has become a routine part of the nursing practice” (p. 346). This might explain why there
is little guidance in the medical literature or academic textbooks. In academic nursing textbooks
regarding cardiac nursing, there are more in-depth explanations regarding post-procedure cardiac
care, but no consensus on bed rest protocols after femoral sheath removal and early ambulation.
(Moser & Riegel, 2008; Wood et al., 2010). An in-depth analysis of the 15 articles revealed
seven themes in the literature around early ambulation after a femoral PCI. The seven themes
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drawn from the literature include: support for four hours early ambulation post-PCI with low-risk
study patients, variable definition differences across the literature, methodology heterogeneity of
the studies, recommended caution from authors when applying results to clinical practice, listed
risk factors with no support for conclusion or correlation to increased vascular complications at
early ambulation (Antonsen et al., 2013; Augustin et al., 2010; Kim et al., 2013; Kobrossi et al.,
2014; Koch et al., 1997; Koch et al., 1999; Mohammady et al., 2013; Rolley et al., 2009; Schiks
et al., 2008; Tongsai & Thamlikitkul, 2012; Walker et al., 2008; Wentworth et al., 2018), little
evidence from CPGs (Levine et. al, 2011; Rolley et al., 2011), and the perceived nursing
education needs for early ambulation in clinical practice (Rolley et al., 2010).
Early Ambulation at Four Hours Post-Femoral PCI. The literature supports that
vascular complications do not increase at early ambulation at less than or at four hours after a
femoral access PCI, but only in low-risk patients (Antonsen et al., 2013; Augustin et al., 2010;
Kim et al., 2013; Kobrossi, et al., 2014; Koch et al., 1997; Koch et al., 1999; Mohammady et al.,
2013; Rolley et al., 2009; Schiks et al., 2008; Tongsai & Thamlikitkul, 2012; Walker et al., 2008;
Wentworth et al., 2018). The low-risk population ranges from excluding patients that had an
unstable or serious medical condition (Antonsen et al., 2013; Augustin et al., 2010; Schiks et al.,
2008), use of GP IIb/IIIa inhibitors (Antonsen et al., 2013), prior oral anticoagulants (Augustin et
al., 2010; Koch et al., 1997), pre-or post-low molecular weight heparin or unfractionated heparin
administration (Augustin et al., 2010; Koch et al., 1999), prior procedure complications
(Antonsen et al., 2013; Koch et al., 1997; Koch et al., 1999), use of larger catheters (Koch et al.,
1997; Schiks et al., 2008), and vascular complications while on bed rest (Tongsai & Thamlikikul,
2012; Walker et al., 2008), as seen in Appendix C. Antonsen et al. (2013) notes that careful
selection of patients may help decrease vascular complications before, during, and after a PCI,
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and even lead to same day discharge, resulting in lower costs for the hospital. However, the
exclusionary indications listed previously are common in patients undergoing a PCI in the acute
care setting and do not make it easy for nurses to apply the research (Rolley et al., 2009; Rolley
et al., 2011; Schiks et al., 2008).
Variable Definition Differences. The second theme observed is varying definitions of
what time frames comprise early ambulation and vascular complication across the literature
(Antonsen et al., 2013; Augustin et al., 2010; Koch et al., 1997; Koch et al., 1999; Kobrossi et
al., 2014; Levine et al., 2011; Kim et al., 2013; Mohammady et al., 2013; Rolley et al., 2009;
Rolley et al., 2010; Rolley et al, 2011; Schiks et al., 2008; Tongsai & Thamlikikul, 2012; Walker
et al., 2008; Wentworth et al., 2018; Wood et al., 2010). Early ambulation within reported
literature ranges from one-and-a-half to six hours (Kim et al. 2013). Vascular complications
varied even greater in definition throughout the literature as bleeding, vascular, or puncture site
complications (Antonsen et al., 2013; Augustin et al., 2010; Koch et al. 1997; Koch et al., 1999;
Kobrossi et al., 2014; Levine et al., 2011; Kim et al., 2013; Mohammady et al., 2013; Rolley et
al., 2009; Rolley et al., 2010; Rolley et al, 2011; Schiks et al., 2008; Tongsai & Thamlikikul,
2012; Walker et al., 2008; Wentworth et al., 2018; Wood et al., 2010).
Bleeding definitions ranged from minor to major bleeding (Augustin et al., 2010),
external bleeding (Wentworth et al., 2018), hemorrhage (Kim et al., 2013), needing further
compression and bed rest (Koch et al., 1997; Koch et al., 1999; Schiks et al., 2008), or requiring
a blood transfusion (Antonsen et al., 2013; Kobrossi et al., 2014). Hematomas were the bestdefined vascular complication within the literature and mainly fell under a vascular site
complication definition as opposed to bleeding or puncture site definition (Antonsen et al., 2013;
Augustin et al., 2010; Kobrossi et al., 2014; Koch et al. 1997; Koch et al., 1999; Kim et al., 2013;
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Mohammady et al., 2013; Schiks et al., 2008; Tongsai & Thamlikikul, 2012; Walker et al., 2008;
Wentworth et al., 2018). Additional vascular complication definitions include small and large
hematomas (Augustin et al., 2010; Kobrossi et al., 2014; Koch et al., 1997; Koch et al., 1999;
Kim et al., 2013; Mohammady et al., 2013; Schiks et al., 2008; Tongsai & Thamlikikul, 2012;
Walker et al., 2008; Wentworth et al., 2018), pseudoaneurysms (Antonsen et al., 2013; Augustin
et al., 2010; Kobrossi et al., 2014; Koch et al., 1997; Koch et al., 1999; Mohammady et al., 2013;
Schiks et al., 2008; Wentworth et al., 2018), AV fistulas (Antonsen et al., 2013; Koch et al.,
1997; Koch et al., 1999; Mohammady et al., 2013; Schiks et al., 2008; Wentworth et al., 2018),
retroperitoneal bleeds (Antonsen et al., 2013; Wentworth et al., 2018), and need for vascular
surgery (Antonsen et al., 2013; Kobrossi et al., 2014; Wentworth et al., 2018). Wentworth et al.
(2018) and Antonsen et al. (2013), were the only studies to use the NCDR definitions of major
bleeding in three categories (Subherwal et al., 2012). Wentworth et al. (2018) also compared
vascular complications noted in the institution’s electronic health record against the NCDR
definitions of vascular complications. The difference between the electronic health record and
professional definitions highlight varying definitions of vascular events from the literature,
professional opinion, and actual clinical practice (Subherwal et al., 2012; Wentworth et al.,
2018). The varying meanings and categories of early ambulation and vascular complications
create another obstacle in applying the literature’s conclusion that early ambulation is safe for
patients after a femoral access PCI (Mohammady et al., 2013; Schiks et al., 2008).
Methodology Heterogeneity. The third theme noted in Appendix C is methodology
heterogeneity throughout the studies. In addition to excluding high-risk populations, the studies
differed in their inclusion characteristics, study selection, study designs, measures, protocols,
power, instruments including using both descriptive and inferential statistics to present results,
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different statistical models, and collecting different types of reported baseline characteristics
(Antonsen et al., 2013; Augustin et al., 2010; Kim et al., 2013; Kobrossi, et al., 2014; Koch et al.,
1997; Koch et al., 1999; Mohammady et al., 2013; Rolley et al., 2009; Schiks et al., 2008;
Tongsai & Thamlikitkul, 2012; Walker et al., 2008; Wentworth et al., 2018). Although the 15
independent studies, find that the risk for vascular complication does not increase post-femoral
access PCI with early ambulation, the heterogeneity of the studies makes it hard to draw a
collective conclusion for application to a realistic clinical situation (Mohammady et al., 2013;
Schiks et al., 2008).
Clinical Practice Caution. The highest LOE from Kim et al. (2013), Mohammady et al.
(2013), and Tongsai and Thamlikikul, (2012), supports early ambulation after a femoral PCI, but
urges caution in interpreting results accounting for patient and procedural risk factors, varying
clinical practices, and methodological flaws. Kim et al. (2013) and Mohammady et al.(2013),
recommend caution in broadly applying study results, and that nurses must take evidence-based
risk factors such sheath size, age, gender, hemostatis technique, and type of adjunctive therapy
used into consideration when making clinical decisions for early ambulation. Varying clinical
practices in the study protocol is observed across all of the experimental and observational
design studies (Antonsen et al., 2013; Augustin et al., 2010; Kobrossi et al., 2014; Koch et al.,
1997; Koch et al., 1999; Schiks et al., 2008; Walker et al., 2008;Wentworth et al., 2018), that
incorporate or exclude many of the risk factors listed by Kim et al. (2013) and Mohammady et
al. (2013), making it hard to compare or tease out vascular risk factors within studies (Antonsen
et al., 2013; Augustin et al., 2010; Kobrossi et al., 2014; Koch et al. 1997; Koch et al., 1999; Kim
et al., 2013; Mohammady et al., 2013; Schiks et al., 2008; Tongsai & Thamlikikul, 2012; Walker
et al., 2008; Wentworth et al., 2018). Methodological flaws, such as inadequately powered
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studies in Mohammady et al. (2013), and bias is evident in all three meta-analyses, which also
decreases the generalizability of the results (Kim et al., 2013; Mohammady et al., 2013; Tongsai
& Thamlikikul, 2012).
Vascular Risk Factor Conclusions in the Literature A fifth theme is the lack of
evidence to show a relationship between vascular complications and patient populations who are
at risk for these types of complications. Within the literature reviewed in Appendix C, baseline
characteristics that are also risk factors are listed and include activated clotting levels, activated
partial thrombin levels (Augustin et al., 2010; Wentworth et al., 2018), female gender, body mass
index, low body weight, advanced age, use of anticoagulants, large catheter size, length of time
the catheter is in place, and underlying peripheral vascular disease (Augustin et al., 2010;
Kobrossi et al., 2014; Koch et al., 1997; Koch et al., 1999; Mohammady et al., 2013; Rolley et
al. 2009; Schiks et al., 2008; Walker et al., 2008). Wentworth et al. (2018) determined with
statistical significance that patients with vascular risk factors had an increase in vascular
complications. Wentworth et al. (2018) found an increase in vascular complications in patients
who received GP IIb/IIIa inhibitors and higher mean activated clotting levels at removal of the
sheath and closure of the site. However, since no correlation coefficient is listed, there is a
difference, but not a relationship between these variables. Making decisions regarding early
ambulation is difficult when the majority of the literature does not concur on the
recommendation for patients with increased vascular risk factors (Augustin et al., 2010; Kobrossi
et al., 2014; Koch et al., 1997; Koch et al., 1999; Mohammady et al., 2013; Rolley et al. 2009;
Schiks et al., 2008; Walker et al., 2008). This conclusion is further confounded by Kim et al.
(2013) and Mohammady et al. (2013). The two meta-analyses concur that risk factors such as
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gender, age, adjunctive therapies, and hemostatis need to be considered when applying these
results to clinical practice (Kim et al., 2013; Mohammady et al., 2013).
Little Evidence from CPGs. The sixth theme that the literature revealed is that CPGs
provide either no evidence (medical) or low-evidence (nursing) for early ambulation after a
femoral access PCI. Both guidelines were graded using the AGREE II tool in the context of the
research question (Brouwers et al., 2010; Levine et al., 2011; Rolley et al., 2011). The medical
guidelines of Levine et al., (2011), see Appendix C and G, were quite specific to the medical
aspects of the procedure, but only indirectly address early ambulation in the context of
adjunctive therapies and vascular compression devices. The evidence-based CPGs from Rolley et
al. (2011) for Australian and New Zealand cardiovascular nurses are specific to PCI nursing
cares and address a gap in both the nursing and medical literature related to care of patients
undergoing a PCI (see Appendix C and H). Rolley et al. (2011) addresses early ambulation
within the CPGs, but the evidence is low per the grading system for evidence &
recommendation. Per Rolley et al. (2011), this may be related to chosen study methodology
heterogeneity, populations chosen, hemostatis methods, adjunctive therapies, multiple
procedures within studies, and varying heparization protocols. In addition, a clear audit of why
studies were chosen was not clear within either guideline. Both guidelines provide valuable
information about the PCI, but they lack high quality evidence to support early ambulation after
a femoral access PCI (Levine et al., 2011; Rolley et al., 2011).
Perceived Nursing Needs in Clinical Practice. Finally, nursing care post-PCI related to
bed rest and early ambulation varies greatly and there is a perceived need for more education.
Rolley et al. (2010) conducted a survey asking cardiovascular nurses about nursing care of
patient undergoing a PCI, addressing another gap in the literature, nursing perception of PCI care
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(see Appendix C). When surveyed about the proper time to initiate ambulation after a PCI, the
majority of nurses selected four hours after a PCI (46.4%), followed by three hours (10.9%), and
two hours (10.9%). The remaining 32% of nurses answered from less than one hour to greater
than eight hours as optimal ambulation time. This can also be reflected in the nurses’ perceived
need for more information on post-PCI procedure complication monitoring and time to
ambulation post-PCI sheath removal. Nurses also rated the time to ambulation post-PCI as
lacking in high LOE within their practice and perceived a statistically significant difference in
the priority of monitoring post-procedure complications and what actually happened in clinical
practice (Rolley et al., 2010). Although this is one study and has methodological flaws (lower
LOE and possible responder bias), Rolley et al., (2010), like Wentworth et al. (2018), points out
a different understanding of the PCI procedure and early ambulation post-procedure from the
nursing perspective and that there is a lack of consistent evidence and standards for nursing to
turn to within the literature to find these answers.
Conclusion. The literature reveals that early ambulation at or before four hours
post-femoral access PCI does not increase vascular complications as compared to later
ambulation in low-risk patients. The results should be used with caution in clinical practice,
considering the differences in definitions of variables, known risk factors to increase
complications, varying clinical practices, methodological flaws of studies, and that these studies
acknowledge potential risk factors, but do not find any major differences or can support a
relationship between the risk factor variables and the increase risk of vascular complications
(Antonsen et al., 2013; Augustin et al., 2010; Kobrossi et al., 2014; Koch et al. 1997; Koch et al.,
1999; Kim et al., 2013; Mohammady et al., 2013; Schiks et al., 2008; Tongsai & Thamlikikul,
2012; Walker et al., 2008; Wentworth et al., 2018). The literature also reveals that there are
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evidence-based CPGs for PCIs, but these guidelines fall short in addressing ambulation post-PCI
(Levine et al., 2011; see Appendix G), and provide low quality evidence to support early
ambulation in the nursing guidelines with no clear trail of why studies were selected (Rolley et
al., 2011; See Appendix H). Finally, although it is only one study, the novel survey by Rolley et
al. (2010), assesses cardiovascular nurses’ perceptions of post-femoral access PCI care and the
difference in perception of early ambulation. The current evidence suggests that nurses who care
for patients undergoing PCI need education on assessing patients for risk factors which could
increase their risk for post-PCI complications (Rolley et al. 2010). Additionally, nurses would
benefit from a guideline that assists them in applying the evidence to all patients, not just those
without risk factors (Levine et al., 2011; Rolley et al., 2011).
Chronic Care Model
The CCM, was first introduced in the 1990s by Wagner et al., (1996a), with support of
the Robert Woods Johnson Foundation to improve outcomes for patients with chronic disease
(Wagner et al., 1996a; Wagner et al., 2001). The globally recognized CCM looks to provide
evidence-based and patient-centered care within a proactive framework for healthcare systems to
improve delivery and outcomes to chronic care populations (Yeoh et al., 2018). The community
and the healthcare system within the model have several different groups that enable better
chronic care. These two groups are intertwined, as the community incorporates and is linked to
the healthcare system (Wagner et al., 2001). Within the community there are resources and
policies, that ultimately influence the groups within the healthcare system. Within the healthcare
system there are the groups of self-management, delivery system designs, decision support, and
clinical information support (CIS). Together, motivated and well-informed patients, along with
proactive and well-educated clinicians can provide high quality chronic illness care. The
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elements from this model that aid addressing how this research can be applied into nursing
clinical practice can be seen in the healthcare system elements of decision support and CIS
(Wagner et al., 2001).
Decision support refers to providing the best care every time to all patients (Wagner et
al., 2001; Yeoh et al., 2018). The decision support tool includes evidence-based guidelines to
guide care. Although Wagner, Austin, and Von Korff (1996b) state there is sometimes push back
around homogenized care that does not look at the unique and individualized needs of the
patient, this “rugged individualism leads to practice variations and failure to adhere to
guidelines” (Wagner et al., 1996b, p. 519). However, guidelines can only be considered useful
and lead to outcome and process improvements if they are credible, relevant, and well-integrated
into a comprehensive practice improvement intervention and into patient care (Wagner et al.,
1996a). A possible way to integrate decision support tools into practice is to place them into the
clinical information systems (CIS). Decision support tools cannot be discussed without
reviewing the CIS element, as these are also based on evidence-based guidelines (Wagner et al.,
2001).
CIS provide the ability to capture and integrate critical information into patient care and
also help clinicians remember to provide evidence-based care (Wagner et al., 2001; Yeoh et al.,
2018). In addition to serving as a reminder for evidence-based guidelines for clinicians, CIS can
serve as a registry for managing population health and providing feedback on quality of care
(Yeoh et al., 2018). The CCM can guide the approach for standardizing a post-PCI ambulation
protocol by incorporating CPGs throughout the CIS in the form of flow sheets, patient
assessment tools, and clinical pathways to help clinicians improve patient care (Wagner et al.,
2001).
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Conclusion, Recommendations, and Nursing Implications
Introduction
The primary purpose of this integrative literature review is to examine recommendations
for ambulation post-PCI. Although PCI is a common procedure routinely performed in the acute
care setting, nurses continue to follow bed rest protocols which have been in place for many
years (Augustin et al., 2010; Kim et al., 2013; Rolley et al., 2010; Schiks et al., 2008). This
section will cover conclusions related to early ambulation post-PCI based on the current
evidence, discuss the implications for nursing practice, as well as provide recommendations for
medical and nursing healthcare providers who care for patients who require a PCI.
Conclusion
This integrative review addresses if early ambulation at or less than four hours postfemoral access PCI, based on general nursing perception of early ambulation (Rolley et al.,
2010), has any impact on a patient’s risk of vascular complications. This review used a rigorous
search strategy to find all relevant literature that addressed early ambulation at or less than four
hours post-PCI. In addition to articles yielded from key terms, all references of reviewed articles
were assessed, all articles referencing reviewed articles in CINHAL were assessed, and a
reassessment of each article was undertaken to assess if the study population included patients
undergoing a PCI and was not limited to cardiac catherization patients (see Appendix A). This
strategy produced 15 articles for the literature review and includes three meta-analyses (Kim et
al., 2013; Mohammady et al., 2013; Tongsai & Thamlikikul, 2012), two evidence-based CPGs
for PCI (Levine et al., 2011; Rolley et al., 2011), one RCT (Augustin et al., 2010), three quasiexperimental studies (Koch et al., 1997; Koch et al., 1999; Walker et al., 2008), one prospective
non-randomized comparative study (Schiks et al., 2008), one survey (Rolley et al., 2010), one
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retrospective cohort study (Antonsen et al., 2013), one retrospective observational study
(Kobrossi et al., 2014), one retrospective case study (Wentworth et al., 2018), and one systematic
integrative literature review (Rolley et al., 2009).
The review found that the literature, especially the three meta-analyses that are the
strongest LOE (Kim et al., 2013; Mohammady et al., 2013; Tongsai & Thamlikitkul, 2012),
answered the research question that early ambulation at four-hour post-femoral PCI does not
increase vascular complications, but only in low-risk patients (Antonsen et al., 2013; Augustin et
al., 2010; Kim et al., 2013; Kobrossi et al., 2014; Koch et al., 1997; Koch et al., 1999; Levine et.
al, 2011; Mohammady et al., 2013; Rolley et al., 2009; Rolley et al., 2010; Rolley et al., 2011;
Schiks et al., 2008; Tongsai & Thamlikitkul, 2012; Walker et al., 2008; Wentworth et al., 2018).
This review also showed that before applying these results to clinical practice, the clinical nurse
needs to consider several factors. The clinical nurse needs to consider a patient’s baseline risk
and procedural factors that may increase a patient’s risk of vascular complications during early
ambulation. The answer to this clinical question is further complicated by gaps in literature
including different definitions of variables, heterogeneity within the studies’ methodology
(Antonsen et al., 2013; Augustin et al., 2010; Kobrossi et al., 2014; Koch et al., 1997; Koch et
al., 1999; Kim et al., 2013; Mohammady et al., 2013; Schiks et al., 2008; Tongsai &
Thamlikikul, 2012; Walker et al., 2008; Wentworth et al., 2018), and little guidance from CPGs
(Levine et al., 2011; Rolley et al., 2011).
Nursing Implications
Implications for nursing from this integrative review first confirm that the nursing
perception of optimal ambulation time for patients post-femoral PCI of four hours or less, is
evidence-based (Abdollahi et al., 2015; Antonsen et al., 2013; Augustin et al., 2010; Kim et al.,
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2013; Kobrossi et al., 2014; Koch et al., 1997; Koch et al., 1999; Levine et. al, 2011;
Mohammady et al., 2013; Rolley et al., 2009; Rolley et al., 2010; Rolley et al., 2011; Schiks et
al., 2008; Tongsai & Thamlikitkul, 2012; Walker et al., 2008; Wentworth et al., 2018). Second,
this review can be used to urge nurse leaders to ensure nurses working in the acute care setting
who care for patients that undergo a PCI receive updated evidence-based education on postprocedural care and how to safely apply evidence into clinical practice (Kim et al., 2013; Rolley
et al., 2010). Third, this review calls for the development of CPGs for nursing care post-PCI, that
can be applied to all patients, not just those with a low-risk for complications (Mohammady et
al., 2013; Rolley et al., 2009; Rolley et al., 2010, Rolley et al., 2011).
Nurses play an invaluable role following PCIs by monitoring for vascular complications
post-procedure (Moser & Riegel, 2008; Woods et al., 2010), yet often are not aware of the
evidence-based literature supporting early ambulation (Tongsai & Tahamlikitkul, 2012), leading
to sacred cow practices such as prolonged bed rest (Abdollahi et al., 2015; Rolley et al., 2010;
Upvall, et al., 2019). Nurses have indicated that education on post-PCI procedure complication
monitoring and time to ambulation after removing the arterial sheath as high educational
priorities (Rolley et al, 2010). Clinical nurses should also be educated on recognition of the risk
factors for vascular complications in order to individualize which patients may not be candidates
for early ambulation at four hours (Antonsen et al., 2013; Kim et al., 2013; Mohammady et al.,
2013; Rolley et al., 2010; Tongsai & Thamlikitkul, 2012).
Evidence-based CPGs for PCI care have been written by Australian and New Zealand
nurses (Rolley et al., 2011), but none have been written for American nurses. American nurses
can access general information about a PCI from Levine et al. (2011), however, the guide does
not address early ambulation directly. The CPGs from Rolley et al. (2011) can serve as a model
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for future guidelines that address post-procedural care within the U.S. As the number of PCI
procedures increase, so will vascular complications (Kim & Zamanian, 2018). CPGs help
standardize practice and provide guidance using the latest evidence, in order to avoid sacred
cows within clinical practice (Rolley et al., 2011; Wagner et al.,1996b; Upvall, et al., 2019).
Recommendations
There are several recommendations from this study. The first recommendation includes
implementing early ambulation at four hours post-femoral access PCI into clinical practice after
a thorough review of a patient’s baseline risk factors and procedural factors that may increase
vascular complications (Antonsen et al., 2013; Kim et al., 2013; Mohammady et al., 2013;
Schiks et al., 2008). The second recommendation is a need to educate nurses on the evidencebased literature to support early ambulation and monitoring for complications (Rolley et al.,
2010). The third recommendation is to address the gaps in the literature by standardizing
vascular definitions within the literature (Singh, 2015). The fourth recommendation is to publish
a RCT in a controlled research environment in order to further standardize results and potentially
draw conclusions about relationships between vascular risk factors, early ambulation, and
vascular complications (Kim et al., 2013;Wentworth et al., 2018). Finally, evidence-based CPGs
should be revised on a routine basis to keep up with the advances in procedural care, technology,
medications, and procedural technique (Levine et al., 2011; Rolley et al., 2011).
Evidence-based CPGs on post-procedural PCI care are needed to provide safe clinical
nursing care within the U.S. In order to be successful, evidence-based guidelines can be wellintegrated into clinical practice and patient care (Wagner, 1996a; Wagner et al., 2001). Using
Wagner’s CCM, evidence-based CPGs, or decision support tools, safe post-PCI nursing care can
be standardized by integration of the evidence into a component of the CIS, within the electronic
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health record (Levine et al., 2011;Rolley et al., 2009; Rolley et al., 2010; Rolley et al., 2011;
Wagner et al., 1996a; Wagner et al., 2001; Yeoh et al., 2018). The guidelines can be integrated
into patient assessment tools and flow sheets that identify risk factors, types of vascular
complications, and how to assess for vascular complications in patients undergoing PCIs.
Clinical pathways that promote early ambulation for low-risk patients can help nurses make
timely and evidence-based decisions that can improve the quality of patient care and even
decrease overall costs of the PCI (Rolley et al., 2009; Wagner et al., 1996a; Wagner et al., 2001;
Yeoh et al., 2018).
Final Summary
Despite the increase in radial access PCIs in the U.S., femoral access remains the most
popular access site for patients undergoing a PCI (Stouffer & Peter, 2016). Patients undergoing
femoral access PCIs deserve optimal, evidence-based care from both the medical and nursing
fields, yet there are barriers to delivering this care in the form of separate evidence-based
guidelines and differing opinions of optimal care (Levine et al., 2011; Rolley et al., 2011). This
integrative review sought to determine if early ambulation at or less than four hours post-femoral
access PCI, based on general nursing perception of early ambulation (Rolley et al., 2010), had
any impact on a patient’s risk of vascular complications. This review used 15 articles (see
Appendix C), found via a rigorous search with varying LOE as defined by Ackley et al. (2008) in
Appendix B. The review found that even the highest LOE (Kim et al., 2013; Mohammady et al.,
2014; Tongsai & Thamlikitkul, 2012), supported early ambulation at less than four hours postPCI did not increase a patient’s risk of vascular complication, but only in low-risk patients.
Before applying these findings to clinical practice, the clinical nurse may need to access other
evidence-based resources to assess how a patient’s demographics and procedural risk factors will
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affect them as a candidate for early ambulation. In addition to these considerations, several other
gaps were identified in the literature including different definitions of variables, heterogeneity
within the studies’ methodology, (Antonsen et al., 2013; Augustin et al., 2010; Kobrossi et al.,
2014; Koch et al., 1997; Koch et al., 1999; Kim et al., 2013; Mohammady et al., 2013; Schiks et
al., 2008; Tongsai & Thamlikikul, 2012; Walker et al., 2008; Wentworth et al., 2018), and little
guidance from CPGs (Levine et al., 2011; Rolley et al., 2011).
The first nursing implication from this integrative review confirms that the majority of
nurses’ perception of optimal ambulation time, of four hours post-femoral access PCI, based on
Rolley et al.’s (2010) survey is supported by evidence from the literature. Rolley et al. (2010) has
shown that there is variation in nursing clinical practice related to PCI care and there is a need
for more nursing education and higher levels of evidence to support post-procedural PCI care.
The second and third nursing implications include updated evidence-based education on PCI
cares and how to safely apply this evidence to clinical practice (Rolley et al., 2010). The final
nursing implication includes a call for an evidence-based CPGs for nursing care post-PCI
(Rolley et al., 2011).
Recommendations from this integrative review include more research to fill gaps in the
literature such as variable definitions, conducting higher LOE research to support early
ambulation, education for clinical nurses, and using the CCM to integrate evidence-based
literature in the form of clinical pathways and patient assessment tools into the electronic health
record (Antonsen et al., 2013; Augustin et al., 2010; Kim et al., 2013; Kobrossi, et al., 2014;
Koch et al., 1997; Koch et al., 1999; Levine et al., 2011; Mohammady et al., 2014; Schiks et al.,
2008; Rolley et al., 2009; Rolley et al., 2010; Rolley et al., 2011; Tongsai & Thamlikitkul, 2012;
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Wagner, Austin, & Von Korff, 1996a; Wagner et al., 2001;Walker et al., 2008; Wentworth et al.,
2018).
As the number of PCIs continue to grow (Kim & Zamanian, 2018), more emphasis
should include the quality of the nursing care for patients undergoing a femoral access PCI.
There is evidence to debunk sacred cow nursing practices such as prolonged bed rest and support
early ambulation, which not only improves patient comfort, but could also have favorable
financial implications (Augustin et al., 2010; Cowper et al., 2019; Mohammady et al., 2014;
Rolley et al., 2009; Rolley et al., 2011; Schiks et al., 2008; Upvall, 2019). Using the CCM,
evidence-based tools and clinical pathways can help nurses successfully and safely integrate
early ambulation into the care of patients who have undergone a femoral access PCI (Antonsen
et al., 2013; Augustin et al., 2010; Kim et al., 2013; Kobrossi, et al., 2014; Koch et al., 1997;
Koch et al., 1999; Levine et al., 2011; Mohammady et al., 2014; Schiks et al., 2008; Rolley et al.,
2009; Rolley et al., 2010; Rolley et al., 2011; Tongsai & Thamlikitkul, 2012; Wagner, Austin, &
Von Korff, 1996a; Wagner et al., 2001;Walker et al., 2008; Wentworth et al., 2018).
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Appendix A
Search Strategy
Date of
Search
9/11/19

Keywords/ Subjects /Filters
Used
Keywords: cardiac catherization

Database/Source
Used

# of Hits
Listed
(Total)

Reviewed

Used
(Total)

Cochrane
Library-Reviews

28

0

0

Cochrane
Library-Trials

39

4

0

Filters: all text, English
9/11/19

Keywords: cardiac catherization
Filters: all text, English

9/11/19

Keywords: cardiac
catheterization or percutaneous
coronary intervention AND
early mobility or early
ambulation or early or early
mobilization AND bedrest or
bed rest or immobilization

CINAHL
Complete

13

13

5

9/12/19

Keywords: cardiac
catheterization or percutaneous
coronary intervention AND
bedrest or bed rest or
immobilization AND guidelines
or protocols or practice
guideline or clinical practice
guideline AND early mobility or
early ambulation or early or
early mobilization

CINAHL
Complete

4

2

0

9/13/19

Keywords: coronary
angiography or coronary
catheterization AND adverse
effects or side effects or negative
effects or complication or risk
AND ambulation or walking or
mobilization

CINAHL
Complete

35

9

0

Filters: 2009-2019; English
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Date of
Search
9/18/19

Keywords/ Subjects /Filters
Used
Keywords: bed rest or bedridden
or immobility AND nursing
AND cardiac catheterization or
percutaneous coronary
intervention

Database/Source
Used

# of Hits
Listed
(Total)

Reviewed

Used
(Total)

CINAHL
Complete

9

9

1

CINAHL
Complete

26

8

2

ProQuest Nursing
& Allied Health
Databases

14

2

0

ProQuest Nursing
& Allied Health
Databases

12

2

1

Ovid Medline

2

0

0

Ovid Medline

209

10

0

PubMed

61

3

0

Filters: 2009-2019; English
9/19/18

Keywords: clinical practice
guidelines AND nursing practice
AND cardiac catheterization or
angioplasty or percutaneous
coronary intervention or
percutaneous cardiac
intervention
Filters: 2009-2019; English

9/19/2019

Keywords: early ambulation
AND percutaneous cardiac
intervention AND bed rest
Filters: 2009-2019, English,
subject term, cardiovascular
disease, peer reviewed

9/19/2019

Keywords: John X. Rolley
Filters: 2009-2019, English

9/21/2019

Key Headings: percutaneous
cardiac intervention OR cardiac
catherization
Filters: 2009-2019; English

9/21/2019

Keywords: percutaneous cardiac
intervention AND Nursing
Filters: English, 2009-2019

9/21/2019

Keywords: cardiac intervention
OR percutaneous cardiac
intervention AND ambulation*
AND femoral*
Filters: 2009-2019, English
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Date of
Search

Keywords/ Subjects /Filters
Used

Database/Source
Used

# of Hits
Listed
(Total)

Reviewed

Used
(Total)

9/21/2019

Keywords: percutaneous cardiac
intervention AND nursing*
AND early ambulation*

PubMed

2

1

0

9/22/2019

Keywords used in guideline
library: percutaneous cardiac
intervention

American College
of Cardiology
Guideline
Database

11

3

1

12/27/2019

Keywords: cardiac
catheterization or percutaneous
coronary intervention AND
early mobility or early
ambulation or early or early
mobilization AND bedrest or
bed rest or immobilization

CINHAL

10

5

0

Filters: up to 2008; English
12/27/2019

Keywords: cardiac
catheterization or percutaneous
coronary intervention, femoral
access, bedrest or bed rest or
immobilization

CINHAL

10

4

0

1/1/2020

Keywords: percutaneous
transluminal coronary
angioplasty, early ambulation or
early mobilization or early
mobility

CINHAL
Complete

22

4

2

1/1/2020

Subject Heading: angioplasty,
transluminal, percutaneous
coronary

CINHAL
Complete

22

14

0

PubMed

46

4

1

Subject: ambulation
1/3/2020

Keywords: pci AND ambulation
AND femoral

Additional Search Methods:
1. All references lists were cross checked and two articles selected
2. Within CINHAL Complete, “Times Cited in this Database” was also reviewed for each
article of interest. No articles yielded.
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Initial Search Strategy Articles Ruled Out:
1. Seven articles that were initially chosen were ruled out after further review. The articles
were ruled out because only diagnostic coronary angiogram patients were used as the
study population, as opposed to percutaneous cardiac intervention or a mixed study
population of the two procedures.
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Appendix B
Ackley, Swan, Ladwig, & Tucker’s Levels of Evidence in Nursing Research
Level of evidence (LOE)

Description

Level I

Evidence from a systematic review or meta-analysis of all relevant RCTs
(randomized controlled trial) or evidence-based clinical practice guidelines based
on systematic reviews of RCTs or three or more RCTs of good quality that have
similar results.
Evidence obtained from at least one well-designed RCT (e.g. large multi-site
RCT).

Level II
Level III

Evidence obtained from well-designed controlled trials without randomization (i.e.
quasi-experimental).

Level IV

Evidence from well-designed case-control or cohort studies.

Level V

Evidence from systematic reviews of descriptive and qualitative studies (metasynthesis).

Level VI

Evidence from a single descriptive or qualitative study.

Level VII

Evidence from the opinion of authorities and/or reports of expert committees.

Note. Reprinted from “Evidence-based nursing care guidelines: Medical-surgical interventions,” by B.J., Ackley, B.A. Swan, G.B.,
Ladwig & S.J., Tucker, 2008, p. 7. Copyright 2008 by Mosby Elsevier. Retrieved from
https://libguides.winona.edu/c.php?g=11614&p=61584
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Appendix C
Literature Table
Citation /
Search Engine

Objectives

Antonsen, L.,
Jensen, L.O., &
Thayssen, P.
(2013). Outcome
and safety of
same-daydischarge
percutaneous
coronary
interventions with
femoral access: A
single-center
experience.
American Heart
Journal, 165(3),
393–399.
https://doi.org/10.
1016/j.ahj.2012.1
1.009

Primary
Objective:
To examine
the
outcomes
and safety
of same
day
discharge
for stable
& low-risk
patients
undergoing
a femoral
access PCI.

Reference ListAccessed via
PubMed

Study
Population/
Sample/Setting
-Patients who had
a femoral access
PCI from Western
Denmark Heart
Registry from
January 1st December 31st ,
2010 (n = 1,809).
Inclusions:
AngioSeal VCDs
& SDD
Exclusions:
Unstable
co-morbidities
(COPD, CHF,
PAD, STEMI,
NSTEMI, renal
dysfunction, &
coagulopathies),
no previous
contrast/
medication
allergies,
procedure
exclusions (use of
GP IIb/IIIa
inhibitors), &
post-procedural
complications,
(lives alone &
stairs in home)

Study Design/Protocol
Methods/Variables/
Measures/Instruments
-Retrospective cohort
study
-Pretreatment w/Aspirin
(300mg) & Clopidogrel
(600mg). AngioSeal
used. Bed rest for two hrs
w/subsequent ambulation.
Patient observed for
additional two hrs prior to
D/C.
Cohort #1: SDD &
low-risk patients
(n = 355)
Cohort #2: All other
femoral access patients
meeting exclusion
category (n = 1,400)
Variables/Measures:
SDD, stroke, adverse
cardiac events, &
vascular events
(hematomas, PAS, RPH,
AV fistulas, & need for
blood transfusion or
vascular surgery) w/in 24
hours & 30 days
post-PCI
Instruments:
Statistical Analysis:
t-test, Mann-Whitney U
test, chi-squared (x2) &
descriptive statistics

Results/
Main Findings

Implications/
Critique

Themes/
Comment

Baseline Characteristics:
Mean age (years old):
Cohort #1: 64.5
Cohort #2: 66.7, p = 0.02
Male Gender (%):
Cohort #1: 76.3
Cohort #2: 71.3, p = 0.06
-No GP IIb/IIIa or Bilirubin
was used for patients in
Cohort #1.
-DAPT was used for 98.1%
of study participants.
Around 1.1%
w/monotherapy (drug not
reported).
Bleeding/Vascular Events
in Cohort #1:
Cohort #1:
-Three patients had
vascular complications
(n = 3).
-One patient admitted
< 12 hrs post-D/C for a
PAS ( n = 1).
-Two patients at 24 hrs
post-D/C had small
hematomas < 5 cm (n = 2).
Cohort #2:
-No discussion on vascular
events.

-SDD in low-risk
patients
undergoing a
femoral access
PCI does not
increase vascular
events 24 hrs or
30 days post-PCI.
-RF such as older
age & DAPT
prior to PCI did
not increase
vascular events in
this study per
authors.
-No discussion on
low # of women
in each cohort.
-Weakness of this
study includes
low LOE,
unequal cohort
size, unequal
gender
distribution, &
potential data
collection bias r/t
study design.

-Early
ambulation in
low-risk, SDD,
femoral access
patients at two
hrs may lead to
low rates of
vascular events
post-PCI.
-Careful
selection of
patients before,
during, & after
PCI can
decrease
vascular
complications.
-SDD may
decrease
healthcare
costs of a PCI.
-A RCT study
with
randomization
would strength
the study’s
conclusions.
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Augustin A.C., de
Quadros A.S., &
Sarmento-Leite
R.E. (2010). Early
sheath removal
and ambulation in
patients submitted
to percutaneous
coronary
intervention: A
randomized
clinical
trial. International
Journal of
Nursing
Studies, 47(8),
939–945.doi:
10.1016/j.ijnurstu.
2010.01.004.

Primary
objectives:
To evaluate
immediate
postprocedure
arterial
sheath
removal,
early
ambulation,
& impact
on major
vascular
complicatio
ns.
Secondary
objective:
To evaluate
minor
vascular
complicatio
ns
between
groups.

-Elective femoral
PCIs in adult
patients in Porto
Alegre, Brazil
from October
2004- December
2005.
Inclusion:
Patients with six
Fr AS & a dosage
100 IU/kg of
unfractionated
heparin
peri-procedure
(n = 347).
Exclusion: Hx of
hemorrhagic
events, aortic
failure, use of
GP IIb/IIIa
inhibitors or oral
anticoagulants
before PCI,
LMWH or
unfractionated
heparin
administration
pre- or postprocedure, BMI >
30, &
hemodynamic
instability postPCI

-RCT
-Pretreatment six hrs
prior w/Aspirin (200 mg)
& Clopidogrel (300 mg).
Computer randomization.
Sheath removed by same
trained nurse w/manual
hemostatis immediately
for post-PCI ACT <350
secs or >350 secs after
90 mins.
IG: Three hrs (n = 172)
CG: Six hrs (n = 175)
Variables/Measures:
Early ambulation, TIB, &
major vascular
complications (hematoma
> 10 cm, PAS, & arterial
bleeding), & minor
vascular complications
(hematoma < 10 cm).
Instruments:
Statistical analysis:
t-test, Fisher’s exact test
or chi-squared statistics
(x 2)
Calculated Sample Size:
Need a sample size of
442 people w/an estimate
of general population rate
w/10% major vascular
complication rates & 7%
between groups.

Baseline characteristics:
No statistical difference
between gender, age, BMI,
ACT, or aPTT.
Vascular Events
IG # (%) vs. CG # (%):
Major Bleeding:
Hematoma: 1 (0.6) vs. 1
(0.6), p = 1.0
PAS: 1 (0.6) vs. 0,
p = 0.37
Arterial Bleeding:
1 (0.6) vs. 0,
p = 0.37
Total Major Bleeding:
3 (1.7) vs. 1 (0.6),
p = 0.31
Minor Bleeding:
Before AS:
4 (2.3) vs. 7 (4),
p = 0.36
After AS:
3 (7.5) vs. 18 (5.2),
p = 0.06

-There is no
statistically
significant
evidence of an
increase in major
vascular events
for immediate six
Fr AS removal
and early
ambulation at
three hrs.
-Minor bleeding
is almost
statistically
significant postarterial sheath
removal & may
be r/t to reduced
weight-based
heparin dosing.
-Weakness
include a small
sample size,
inadequate power
& potential
sample bias.
-Caution should
be taken when
interpreting these
results r/t the
weaknesses listed
above.

-Early
ambulation at
three hrs
may not be
significantly
significant for
major
bleeding, but
minor bleeding
may occur.
-Weight-based
heparin dosage
may play a role
in decreased
vascular risk
postprocedure.
-No difference
in baseline
characteristics
for bleeding
risk.

CINAHL
Complete
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Kim, K., Won, S.,
Kim, J., Lee, E.,
Kim, K., & Park,
S. (2013). Metaanalysis of
complication as a
risk factor for
early ambulation
after percutaneous
coronary
intervention.
European Journal
of Cardiovascular
Nursing, 12(5),
429–436. doi:
10.1177/1474515
112462519

Primary
Objective
To examine
& reassess
previous
studies for
the effect
of early
ambulation
on vascular
complicatio
ns in
patients
post-PCI.

CINAHL
Complete

Study
Population/
Sample/Setting
-149 articles
identified & 15
articles selected
(n = 4,785)
-Seven RCTs &
eight quasiexperimental
studies.
Inclusion:
English/Korean
language,
published from
1990-2011, &
select keywords
Exclusion: No
control group,
different
measures/
outcomes, > three
comparison
groups, case
studies, & no
statistical
analysis; radial
artery access or
procedural device
studies; &
procedure prior to
PCI.
Databases:
PubMed,
CINAHL, & The
Cochrane Library

Study Design/Protocol
Methods/Variables/
Measures/Instruments
-Systematic literature
review & meta-analysis
Variables/Measures:
TIB, early ambulation, &
major vascular
complications
(hemorrhage & puncture
site hematoma)
IG: Early ambulation
(one-and-a-half-six hrs)
CG: Late (three hrs to
next morning) ambulation
Instruments:
Bias: Regression analysis
(Macaskill’s test) &
Funnel plots
Heterogeneity: chisquare-based statistics
(x2)
Effect size: OR
Outcomes: Mantel–
Haenszel statistics
& Forest plots

Results/
Main Findings

Implications/
Critique

Themes/
Comment

Bias:
Hematoma:
p = 0.353
Hemorrhage:
p = 0.728
-Funnel plot “nearly
symmetrical” (p.433)
Heterogeneity:
Hematoma events:
x2 = 8.63, p = 0.8003
Hemorrhage: x2 = 6.59,
p = 0.7632
Measures:
-Fixed effects model
Hematoma events:
OR = 0.89,
95% CI = 0.68–1.17
Hemorrhage:
OR = 1.14,
95% CI = 0.77–1.7
-Nine studies conducted
after 2001 had an earlier
ambulation range from oneand-a half to four hours.
-Six studies conducted
prior to 1990 had early
ambulation at two-and-a
half to six hrs.

- DiCenso,
Guyatt, &
Ciliska’s MetaAnalysis Tool
used, see
Appendix D.
-Assuming a
fixed-effect
model, there is no
increase in
vascular events at
the puncture site
r/t to early vs. late
ambulation postPCI pts.
-Should consider
usage of
antiplatelet or
anticoagulants,
sheath size,
gender, age, &
hemostasis
techniques when
applying results.
-Weaknesses
include a low
powered test, to
assess publication
bias, no other
heterogeneity
tests, & including
studies that define
early ambulation
at six hrs.

-Early
ambulation
may not
increase
vascular events
in pts
undergoing a
post-femoral
access PCI.
-Later studies
ambulated
patient w/
earlier
timeframes.
-Consider
sheath size,
adjunctive
therapies,
gender, age, &
hemostasis
technique.
-Currently
using as the
study despite
early
ambulation up
to six hrs,
because it
systematically
looks at many
early
ambulation
studies to
produce a
higher LOE.
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Kobrossi, S.,
Tamim, H., &
Dakik, H. A.
(2014). Vascular
complications of
early (3 H) vs
standard (6 H)
ambulation postcardiac
catheterization or
percutaneous
coronary
intervention from
the femoral artery.
International
Journal of
Cardiology. 176
(3), 1067–1069.
doi:
10.1016/j.ijcard.2
014.07.137

Primary
Objective:
To assess if
early
ambulation
at three
hours vs.
the
standard
time of six
hours post
CC & PCI
is safe.

Reference ListAccessed via
PubMed

Study
Population/
Sample/Setting
-Patients
undergoing a CC
alone, or with a
PCI.
Inclusions:
Patients
undergoing CC
and/or PCI with
either a five or six
French arterial
sheath (n = 262).
Exclusions:
None stated.

Study Design/Protocol
Methods/Variables/
Measures/Instruments
-Retrospective
observational study
-All procedures
completed by an
experienced
interventional
cardiologist w/cardiac
fellow pulling AS. If only
a CC, AS was removed,
& 15 mins of manual
hemostasis. For a PCI,
the sheath was removed
three to four hours after
procedure w/15 minutes
of manual compression.
Patients stayed 24 hours
post-procedure.
Ambulation per group.
EA: Three hrs (n = 147)
LA: Six hrs (n = 115)
Variables/Measures:
TIB, ambulation time, &
vascular complications
(bleeding, hematoma, &
PAS)
Instruments:
Large Hematoma: > five
cm by five cms
Bleeding: Any bleeding
requiring transfusion
Vascular Complications:
Requiring surgical
intervention
Statistical Analysis:
Descriptive & Chi
squared statistics (x2), &
t-test

Results/
Main Findings

Implications/
Critique

Themes/
Comment

Baseline Characteristics
EA # (%) vs. LA # (%):
Anticoagulation:
LMWH: 0 vs 5 (4.3),
p < 0.01
Warfarin: 0 vs. 3(2.6%),
p = 0.05
Six Fr AS: 128 (87) vs. 114
(99), p < 0.001
-No difference in gender,
age, & BMI.
-Most patients undergoing
PCI were in the LA group
(21%) vs. the EA group
(4.5%).
Vascular Complications
EA # (%) vs. LA # (%):
PAS:1 (0.7) vs. 1 (0.9),
p = 0.97
Any Hematoma:
3 (2.0) vs. 2(1.7),
p = 0.97
Large Hematoma:
2 (1.4) vs. 2 (1.7),
p = 0.96
-No hematomas after
ambulation, only after
sheath pull.
Overall Vascular
Complication Rates:
2.7 % vs. 2.6 %,
p = 0.9

-No difference
between
ambulation at
three hrs vs. six
hrs in vascular
complications
after a femoral
CC/PCI.
-Larger sheaths &
more
anticoagulation
within the EA vs.
LA group
w/similar
vascular
complications.
-Despite the
lower LOE &
non-randomized
groups, this study
realistically looks
at changing
hospital protocols
& cardiologist
decisions about
which patients
can undergo a
PCI.
-Weaknesses
include LOE,
possible bias from
having one MD
performing the
PCI, & low PCI
representation in
the early
ambulation group.

-Changing
from a six hr
LA to EA at
three-hour
ambulation
may not
increase
vascular
complications
in patients
receiving a CC
with or without
a PCI in this
study’s
patients.
-The baseline
characteristics
(sheath size &
anticoagulation
) did not
increase the
complications
within the EA.
-Study limited
by poor PCI
representation,
but could
reflect realistic
decisions made
within the
overall CC/PCI
population.
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Koch, K.T., Piek,
J.J., de Winter,
R.J., Mulder, K.,
David, G.K., Lie,
K.I, . . . Lie, K. I.
(1997). Early
ambulation after
coronary
angioplasty and
stenting with six
French guiding
catheters and lowdose
heparin. American
Journal of
Cardiology, 80(8)
,1084–1086. DOI:
10.1016/S00029149(97)00609-7

Primary
Objective:
To assess
the
feasibility
& safety of
ambulation
for patients
at four
hours vs.
the next
morning
after an
elective CA
& stenting
by
measuring
bleeding at
or during
ambulation.
Secondary
Objective:
To assess
PCS
within 48
hours of
the
procedure.

Reference ListAccessed via
PubMed

Study
Population/
Sample/Setting
-Elective CA
using six Fr AS
via the femoral
approach at the
University of
Amsterdam
Academic
Medical Center.
Inclusions:
Morning
procedures
(n = 830)
Exclusions: On
oral
anticoagulants or
IV heparin prior
to procedure,
preexisting
hematoma after
recent CC, stent
types needing
larger catheter for
placement,
requiring larger
catheter size, &
continuation of
heparin treatment.

Study Design/Protocol
Methods/Variables/
Measures/Instruments
-Quasi-experimental w/
no randomization
SP: Pretreatment
w/Aspirin (100 mg). Six
Fr AS used in procedures
w/a 5,000 IUs heparin IV
(2,500 IUs given if the
procedure was > 90
mins). AS was removed
immediately, manual
compression was applied,
& maintained w/a
compression bandage.
Supine TIB until
ambulation.
IG: Four hrs (n = 420)
CG: Next morning
(n = 410)
Variables/Measures:
TIB, early ambulation, &
puncture site & vascular
complications (bleeding
at or during ambulation
or PSC 48 hours postPCI)
Instruments:
Bleeding: Further
compression & bed rest
PSC: Groin hematoma >
five by five cms, PAS, &
AV fistula confirmed by
ultrasound
Statistical Analysis:
Descriptive statistics

Results/
Main Findings

Implications/
Critique

Themes/
Comment

Baseline Characteristics
IG vs. CG:
Mean Age (SD):60 years
old (15.6 years) vs. 61
years old (11 years)
Men # (%): 312 (74) vs.
295 (72)
Mean Weight (SD): 81 kg
(9.3 kg) vs.79 kg (8.1 kg)
Hemostasis Time (SD):
n = 9.6 mins (2.5 mins) vs.
9.9 mins (2.6 mins)
Bleeding/Vascular Events
IG # (%) vs. CG # (%):
All bleeding events:
10 (2.3) vs. 9 (2.2)
Bleeding before
Ambulation: 1 vs. 1
Bleeding after Ambulation:
3 vs. 0
Late Bleeding > 48 hours:
1 vs. 1
Hematoma: 4 vs. 5
AV Fistula: 0 vs.1
False aneurysm: 1 vs.1
-Two patients did not
ambulate in IG, one r/t to
bleeding throughout bed
rest & one r/t to a
hematoma > five cms when
compression bandage
removed.

-Four hours vs.
overnight
ambulation after
an elective
CA/PCI w/low
dose heparin via
femoral route is
safe w/low &
comparable rates
of vascular
complications.
-Early ambulation
may decrease
hospital stay.
-Weaknesses of
study include the
statistical method,
lack of
randomization,
selection, & more
specific methods
(timeframe &
reason for
statistical
methods chosen).
-The statistical
analysis included
descriptive
statistics, which
does not allow the
authors to
generalize beyond
the study, but
describe patterns
in the data.

-Patients
undergoing a
femoral access
PCI may be
able to
ambulate four
hours vs.
overnight after
AS pull w/a
low heparin
dose within
this study.
-A stronger
study w/
proper
statistical
analysis &
methods, & a
more realistic
PCI population
would be
needed to infer
if this can be
generalized to
the femoral
PCI
population.
-Baseline
characteristics
were similar
across groups,
w/a larger
percentage of
men in both
groups.
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Koch, K.T., Piek,
J.J., de Winter
R.J., Mulder K.,
Schotborgh, C.E.,
Tijssen, J.G.P, …
Lie, K.I. (1999).
Two-hour
ambulation after
coronary
angioplasty and
stenting with 6 F
guiding catheters
and low dose
heparin. Heart, 81
(1), 53–56. DOI:
10.1136/hrt.81.1.5
3

Primary
Objective:
To assess
the safety
&
feasibility
of
ambulation
of patients
at two
hours after
an elective
CA,
stenting, or
both
procedures
by
measuring
bleeding at
or during
ambulation.
Secondary
Objective:
To assess
PCS within
48 hours
of the
procedure.

Reference ListAccessed via
PubMed

Study
Population/
Sample/Setting
-Elective CA vis
the femoral
approach using
six Fr AS at the
University of
Amsterdam
Academic
Medical Center.
Inclusions:
Morning
procedures at the
facility (n = 300).
Exclusions: Prior
to procedure was
on IV heparin or
oral
anticoagulants;
preexisting
hematoma after
recent CC,
anticipated
prolonged
heparinization
after angioplasty,
& afternoon
procedures.

Study Design/Protocols
Methods/Variables/
Measures/Instruments
-Quasi-experimental
group w/no control group
or randomization.
-Pretreatment w/Aspirin
(100 mg). Six Fr AS for
procedures performed
w/a 5,000 IU heparin IV
(2,500 IU given if the
procedure was > 90
mins). AS was removed
immediately, manual
compression was applied,
& maintained w/a
compression bandage.
Two hrs supine bed rest.
IG: Ambulation at two
hours post-op (n = 300)
Variables/Measures:
TIB, early ambulation,
PSC, & vascular
complications (bleeding
at or during ambulation
or PSC 48 hours postPCI).
Instruments:
Bleeding: Further
compression & bed rest.
PSC: Groin hematoma >
five by five cms, PAS, &
AV fistula confirmed by
ultrasound.
Statistical Analysis:
Descriptive statistics

Results/
Main Findings

Implications/
Critique

Themes/
Comment

Baseline characteristics
(% of participants):
Mean Age: 60 years old
(10.7%)
Men # : 237 (80%)
Mean Weight:79 kgs
(12.3%)
Patients treated
w/additional Heparin #: 12
(4%)
Time to hemostasis: 9.6
mins (3.2%)
Bleeding at Ambulation:
-5 patients (1.7% of
participants)
-Three patients had balloon
angioplasty & two had stent
placement.
-Two patients ambulated
later than two hours, three
patients at four hours, &
two patients after an
overnight bed rest.
48 Hour Puncture Site
F/U # (%):
Late bleeding: 0
Hematoma: 9 (3%)
-Six patients w/hematomas
had balloon angioplasty &
three w/hematomas had
stent placement.
AV Fistula: 0
False aneurysm: 0

-Per authors,
ambulation two
hours postelective CA/
stenting
procedures w/low
dose heparin via
the femoral route
is safe with low
rates of puncture
site complications
and bleeding.
-Weakness of
study include the
descriptive
statistical method
used, lack of a
control group,
lack of reporting
timeframe, reason
for statistical
methods chosen,
& low-risk patient
selection.
-The descriptive
statistics as the
statistical analysis
does not allow the
authors to
generalized
beyond the study,
but describe
patterns in the
data.

-Low-risk
patients
undergoing a
femoral access
PCI were able
to ambulate
two hours after
AS pull w/a
low heparin
dose.
-A study w/a
stronger
methodology
statistical
analysis, & a
realistic
population
will be needed
to infer if this
can be
generalized to
the patients
undergoing
femoral PCIs.
-Larger
percentage of
men in both
groups.
-A shortened
hospital stay
may have
financial
implications.
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Levine, G.N.,
Bates, E.R.,
Blankenship, J.C.,
Bailey, S.R.,
Bittle, J.A.,
Cereck, B. . . .
Ting, H.H.
(2011). 2011
AACF/AHA/
SCAI guideline
for percutaneous
coronary
intervention: A
report for
American College
of Cardiology
Foundation/Ameri
can Heart
Association task
force on practice
guidelines and the
Society of
Cardiovascular
Angiography and
Intervention.
Journal of the
American College
of Cardiology, 58
(24), e44-122.
https://doi.org/10.
1016/j.jacc.2011.0
8.007
American
College of
Cardiology

Primary
Objective:
To
establish
evidencebased
CPGs to
provide
appropriate
& safe care
w/ positive
clinical
outcomes
for PCIs.

Study
Population/
Sample/Setting
-CPGs for North
American adult
patients
undergoing PCIs.
-Literature
searched from
November 2010
to August 2011.
-Writing
committee
composed of
physician experts
in general,
interventional, &
critical care
cardiology;
cardiothoracic
surgery; clinical
trials research in
health services;
& members of
AHA, SCAI, &
ACCF.
Inclusion:
English language
studies & reviews
conducted on
human subjects
Exclusion/
Databases:
Not stated.

Study Design/Protocol
Methods/Variables/
Measures/Instruments
-Evidence-based CPGs
Measures: CAD
revascularization,
preprocedural,
procedural, & postprocedural
considerations; PCI
outcomes; quality &
performance; & future
challenges.
Instruments:
Internal Guideline
Review Tool: Class of
Recommendations and
LOE or CC/AHA
Clinical Practice
Guideline
Recommendation
Classification System
Guideline Review Tool:
AGREE II score of 80%
to be considered high
quality guidelines to
guide the PICO question
& intervention.

Results/
Main Findings

Implications/
Critique

Themes/
Comment

-The key terms ambulation,
early ambulation, &
decreased bed rest, were
searched throughout the
document w/no sections on
the topic & only a small
amount of indirect
references to the
intervention through
sections on adjunctive
therapies & VCDs.
-Early ambulation is only
mentioned in reference to
VCDs (Class IIa, LOE B).
-Routine VCDs do not
decrease vascular
complications (Class III,
LOE B).
AGREE II:
Domain 1: 67%
Domain 2: 27%
Domain 3: 58%
Domain 4: 28%
Domain 5: 46%
Domain 6: 100%
Overall Quality r/t PICO
question: Poor to fair
Use? Yes, with major
modification.

- See Appendix G
for AGREE II
scores.
-The first CPG
for PCIs, but no
guidance on early
ambulation, TIB
or data regarding
vascular
complications r/t
early ambulation.
-The CPGs were
broad in scope &
purpose, but more
specific to
medical aspects
of the procedure.
-The clarity
presentation, &
applicability are
low at 28% &
46% r/t to the
PICO question.
-The ability to
replicate is not
easy to follow,
leading to a score
of 67% in rigor of
development.
-The CPGs
should be revised
w/major
modifications &
input from all
professional
involved.

-There is no
direct guidance
for early
ambulation &
data on the risk
of vascular
complications
w/in the PCI
CPGs from the
medical
community.
-This CPG
could be more
rigorous in
almost all
domains as
assessed by the
AGREE II
tool.
-No update
since original
publication
data in 2011.
-Updates
should include
input from
other
healthcare
professionals
involved in the
procedure.
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Mohammady, M.,
Atoof, F., Sari, A.
A., & Zolfaghari,
M. (2013). Bed
rest duration after
sheath removal
following
percutaneous
coronary
interventions: A
systematic review
and metaanalysis. Journal
of Clinical
Nursing (John
Wiley & Sons,
Inc.),23(11–12),
1476–1485. doi:
10.1111/jocn.123
13.

To explore
the bed rest
duration
after PCI
AS
removal &
incidences
of vascular
complicatio
ns
(hematoma,
bleeding,
PAS, &
AV
fistulas),
back pain,
& urinary
retention.

-5,857 articles
yielded & five
RCTs & quasiexperimental
articles published
up to May 2012
(n = 1,115).
Inclusion: 18+,
receiving PCI,
any sheath size, or
hemostasis
methods after the
procedure, &
three timeframe
comparison
groups (see
Timeframe
Groups in next
column)
Exclusion: Nonrandomized
design, no CG &
additional
interventions
Databases: The
Cochrane Library,
IranDoc,
MEDLINE,
SCOPUS,
CINAHL, &
IranMedex

-Systematic literature
review & meta-analysis
Variables/Measures:
TIB, ambulation times, &
vascular complications
(hematomas, bleeding,
PAS & AV fistulas)
Timeframe Groups:
G1: Two-four hours vs.
six hours of bed rest
G2: Four to six hours vs.
eight hours of bed rest
G3: Three vs. 10 hours of
bed rest
Instruments:
Bias:
The Cochrane
Collaboration Risk of
Bias Assessment Tool
Heterogeneity:
Chi-square statistics (x2),
p > 0.10,, & measures of
inconsistency, I 2 < 50%
Statistical Analysis:
Effect size: OR
Outcomes:
Mantel-Haenszel &
Forest plots

Bias: All studies had
methodological flaws &
80% of the studies had an
unclear risk of bias.
Measures &
Heterogeneity (H):
Two-Four vs. Six hrs:
Hematomas: Z = 0.33,
p = 0.74, H: x2 = 0.01,
p = 0.94, I 2 = 0
Bleeding: Z = 0.08, p =
0.93, H: x2 = 0.07, p = 0.79,
I 2= 0
PAS: Z = 0.26, p = 0.79,
H: Vlasic et al. (2001) only
AV Fistula: N/A, no events
in Vlasic et al. (2001)
Three vs. 10 Hours:
Hematoma: Z = 0.01, p =
0.99, H: Augustin et al.
(2010) only
Bleeding: Z = 0.97, p=0.33,
H: Augustin et al. (2010)
only
PAS: Z = 0.69, p = 0.49,
H: Augustin et al. (2010)
only
AV Fistula: No studies
reporting.

- DiCenso,
Guyatt, &
Ciliska’s (2005)
Meta-Analysis
Tool used, see
Appendix E.
-Assuming a
fixed-effect
model, there is no
significant effects
on the incidences
of hematoma
formation,
bleeding, PAS, &
AV fistulas.
-Recommends
caution when
applying these
results r/t sample
size, definition of
early vs. late
ambulation,
methodological
flaws, hemostasis
methods, unclear
bias risk, & lack
of consistent f/u
times.
-Despite caution
recommended in
clinical practice,
it is still a high
LOE for short
TIB, & early
ambulation after a
femoral PCI.

-Post-PCI pts,
can be
ambulated
from three to
four hrs
without an
increase in
hematomas,
bleeding, PAs,
& AV fistulas.
-Continue to
assess varied
study results in
clinical
practice;
consider
gender, age,
adjunctive
therapies used,
hemostasis
method, &
other flaws in
methodology.
-Although not
stated by
authors, it is
unclear if the
vascular
complications
have similar
definitions
across studies.
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Rolley, J. X.,
Davidson, P. M.,
Salamonson, Y.,
Fernandez, R., &
Dennison, C. R.
(2009). Review of
nursing care for
patients
undergoing
percutaneous
coronary
intervention: A
patient journey
approach. Journal
of Clinical
Nursing, 18(17),
2394. doi:
10.1111/j.13652702.2008.02768.
x.

Primary
Objective:
To assess
existing
literature to
help inform
nursing
manageme
nt of
patients
undergoing
PCIs.

ProQuest
Nursing & Allied
Health Database

Study
Population/
Sample/Setting
-Articles
published about
the care of PCI
published
between 20002009.
-Selected or # of
articles not listed.
Inclusion: CPGs
r/t PCI, ACS, &
secondary
prevention,
descriptive,
interventional, or
systematic
reviews
explaining patient
or nursing care
related to PCIs &
published in
English.
Exclusion: Not r/t
nursing care or
the selected
framework.
Databases:
CINAHL,
MEDLINE,
Cochrane,
Jonna Briggs,
Google Scholar,
& selected
articles’
reference lists

Study Design/Protocol
Methods/Variables/
Measures/Instruments
-Systematic integrative
literature review
Framework & Model:
-Conceptual framework
of the patient journey.
-Focus on post-PCI
(monitoring, groin care,
sheath removal,
ambulation, &
management of PCI
complications).
Wagner’s
Chronic Care Model:
-Model is personcentered & outcome
approach focused.
-Elements from model
used include: patient &
family’s needs are the
focus of care; selfmanagement empowers
patients to better their
own health; skilled
clinicians &
evidence-based educated
patients can collaborate;
decision-support tools
can help clinicians
provide evidence-based
care; supportive policies
can inform care delivery;
& computer information
systems can enhance care
of individual patients &
populations.

Results/
Main Findings

Implications/
Critique

Themes/
Comment

Peri-PCI:
Monitoring/
Complication Recognition:
-RF for vascular access site
complications include age,
gender, weight, AS size,
AS dwelling time,
anticoagulation therapy, &
PCI vs. CC or CA.
Sheath Removal:
-Limited literature
w/methodological
heterogeneity & small
sample size (in studies
looking at skills, training,
evidence to guide AS
removal), & policies that
minimize vascular
complications.
Hemostatis Method: No
difference in studies
between methods.
Early Ambulation:
-Limited consensus &
consistency
-Even w/TIB shortened to
two hours, there is limited
evidence for vascular &
access site complications.

-Evidence-based
CPGs & nursing
sensitive
outcomes for
nursing specific
cares r/t PCI
needed due to the
lack of guidance
in the medical
literature.
-During post-PCI
cares, nurses need
to be aware a
patient’s RF for
vascular
complications.
-TIB at two hours
shows little risk
for vascular site
complications.
- Care maps &
clinical pathway
guidelines can
guide care,
identify RF for
vascular
complications.
-Despite
methodological
weaknesses, this
study is essential
in identifying a
gap in the
literature r/t
nursing care of
the patient
undergoing a PCI.

-There is need
for nursing
evidence-based
CPGs, &
nursing
sensitive
outcomes for
the patients
undergoing a
PCI.
-Care maps &
clinical
pathways can
assist in
making nurses
aware of the
RF for
bleeding/
vascular
complications
& standardize
PCI care.
-Limited
evidence to
support
prolonged TIB
past two hours.
-Limited
consensus &
consistency in
literature r/t
TIB & early
ambulation.
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Rolley, J.X.,
Salamonson Y.,
Dennison C., &
Davidson, P.M.
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10.1097/JCN.0b0
13e3181bb419d.

Primary
Objective:
To describe
priorities,
practice
standards,
workplace
values, &
educational
needs of
Australian
& New
Zealand
CV nurses
around PCI
procedure
from a 116item
survey.
Secondary
objective:
This survey
is part of a
systematic
approach
for nursing
CPG
developme
nt
including
an
integrative
review &
census
conference.
.

CINAHL
Complete

Study
Population/
Sample/Setting
-RNs w/an
average of 12.3
years of
experience
working in the
CV setting
(n = 148), only
110 RNs finished
the survey from
March 20082009.
- 41 experts on the
writing committee
consisted(CV
RNs, professional
organizational
members, &
consumer
representatives)
Inclusion:
Members of CV
nursing
professional
organizations in
Australia & New
Zealand who
voluntarily
answered the
survey, & anyone
who accessed via
a commercial
online survey
platform.

Study Design/Protocol
Methods/Variables/
Measures/Instruments
-Descriptive/survey
- Prior survey from
consensus conference of
CV experts & literature
review informed current
survey.
-Twelve CV experts
evaluated survey prior to
a pilot test.
Measures: Ambulation
time, CPS (what is
optimal practice & what
actually happens), HDV
(perception of LOE to
support nursing cares), &
knowledge & capacity
(further education).
Instruments:
Data:
Electronic survey
Sampling: Voluntary
response & snowballing
effect
Sections:
Categorical or 10-point
Likert item scale
Internal Consistency:
Cronbach’s alpha
HDV/Ambulation Time/
Knowledge & Capacity:
Descriptive statistics

Results/
Main Findings

Implications/
Critique

Themes/
Comment

Internal Consistency
participants:
CPS: n = 6 (.65)
HDV: n = 16 (.88)
Knowledge & Capacity:
n = 14 (.89)
Optimal ambulation time
Post-PCI in hrs:
< One: n = 1 (0.9%)
One: n = 3 (2.7%)
Two: n = 12(10.9)
Three: n = 12 (10.9%)
Four: n = 51 (46.4%)
Five: n = 2 (1.8%)
Six: n = 17 (15.5%)
Seven: n = 9 (8.2%)
> Eight: n = 3 (2.7%)
CPS:
Monitoring
Groin Post-PCI: n = 110,
p = 0.002
HDV:
Time to Ambulation PostPCI:
-Ranked #9 (ranked low)
- 6.22 +/- 2.52 (n = 115)
Education Needs:
Post-PCI Procedure
Complication Monitoring: -Ranked #3 (high need)
-4.13 +/-2.95 (n=115)
Time to ambulation postPCI sheath removal:
-Ranked #4 (high need)
-4.12 +/- 2.81(n = 115)

-Internal
consistency fair to
good.
-Average
perceived time for
ambulation postPCI was four hrs.
CPS: Difference
in clinical
practice
monitoring of
puncture sites
post-PCI.
HDV: RNs
ranked low LOE
to support time to
ambulation at
nine out of ten.
Knowledge &
Capacity: RNs
ranked high
education needs
for monitoring &
ambulation time.
-Weaknesses
include sampling
method (inability
to confirm,
response rate),
potential
responder’s bias,
& descriptive
statistics usage.
-This study
addresses a gap
both nursing &
medical literature.

-Ambulation
time &
monitoring
complications
post-PCI vary
greatly
according to
nursing
perception in
clinical
practice.
-Average
ambulation
time per RN
perception is
four hours.
-RNs rated the
perceived LOE
for ambulation
as low &
highly ranked a
higher
education
needs for postPCI
ambulation &
complications
monitoring.
-There is a
need for
standard CPGs
to guide
nursing care
for patients
undergoing
PCIs.
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Rolley, J. X.,
Salamonson, Y.,
Wensley, C.,
Dennison, C. R.,
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M. (2011).
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Primary
Objective:
To present
a set of
nursing
CPGs for
patients
undergoing
a PCI w/a
summarize
d version
of the
supportive
evidence.

CINAHL
Complete

Study
Population/
Sample/Setting
-CPGs for nursing
care of adult
patients
undergoing a PCI,
developed w/in
the context of
nursing practice in
Australia & New
Zealand.
-Developed by
CV RNs w/a
systematic
literature review
(see Rolley et al.,
[2009] in
literature table for
timeframe,
inclusion,
exclusion, &
databases),
consensus
development
workshop, online
survey of CV RNs
(see Rolley et al.,
[2010] in
literature table), a
modified online
Delphi Technique,
& finally a review
by an
interdisciplinary
panel prior to
submission.

Study Design/Protocol
Methods/Variables/
Measures/Instruments
-Evidence based
guidelines.
Measures: Nursing
practices grouped into
pre-PCI, peri-PCI, &
post-PCI.
-Baseline characteristics
that are risk factors for
vascular complications.
-Within post-PCI
practices ambulation
post-sheath removal was
addressed in general and
with usage of several
adjunctive therapies (GP
IIb/IIIa inhibitors &
Bivalirudin).
Instruments:
Internal Guideline
Review Tool:
-Grading system for
evidence &
recommendation
(GRADE).
Guideline Review Tool:
-AGREE II
-A score of 80% was
considered high quality
guidelines r/t to the PICO
question.

Results/
Main Findings

Implications/
Critique

Themes/
Comment

Baseline Characteristic
RF: Bleeding
Complications:
Adverse coagulation
profile, older age, sheath
size ( > seven Fr AS), &
females (LOE D).
RPH: Females, multiple
punctures within procedure,
& high & small femoral
arteries (LOE B).
Early Ambulation PostPCI:
General: Two to four hours
bed rest, unless clinical
conditions indicate
otherwise(LOE D).
Adjunctive therapies:
Bivalirudin: Can decrease
bed rest from two to four
hours & start early
ambulation, (LOE B).
AGREE II:
Domain 1: 94%
Domain 2: 83%
Domain 3: 82%
Domain 4: 84%
Domain 5: 79%
Domain 6: 83%
Overall Quality r/t PICO
question: Good
Use? Yes, with minor
modifications

-AGREE II was
used, see
Appendix H.
- Scope &
purpose domain is
94%, showing
CPGs are specific
to nursing care r/t
a PCI.
-Despite all
categories almost
meeting 80% for
a high-quality
guideline, minor
modifications are
needed.
- Weak evidence
for early
ambulation from
two to four hours
may be r/t
heterogenous
methodology,
populations,
hemostasis
methods,
adjunctive
therapies, &
multiple
procedures.
-First nursing
CPGs r/t PCI
nursing clinical
practice & should
be translated with
caution into
practice.

-Nursing
guidelines for
care of patients
undergoing
PCIs adds to a
gap in the
medical
literature.
-Varied
evidence for
early
ambulation.
-RF &
adjunctive
therapies
should be
taken into
consideration
for CPG &
actual practice
to prevent
vascular
complications
-Minor
modifications
would strength
the CPG.
-Medical
guidelines
should
combine
information
from these
CPGs for
holistic PCI
guidelines.
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Aengevaeren
W.R.M.,
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Achterberg T., &
Verheugt, F.W.
(2008).
Ambulation after
femoral sheath
removal in
percutaneous
coronary
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al of Clinical
Nursing (WileyBlackwell), 18
(13), 1862–1870.
doi:
10.1111/j.13652702.2008.02587.
x

Primary
Objective:
Investigate
if
ambulation
at four
hours vs.
ten or more
hours after
arterial
sheath
removal in
a PCI has
an impact
on PSC.
Secondary
Objective:
To assess
differences
between
groups r/t
vasovagal
collapse
after
mobilizatio
n, back
pain &
problems
with
voiding.

CINAHL
Complete

Study
Population/
Sample/Setting
-Elective femoral
PCI w/ six Fr AS
in adults at
Radboud
University
Nijmegen
Medical Centre in
Nijmegen,
Netherlands from
February 2001–
2003.
Inclusion:
Procedure prior to
noon. Exclusion:
CA procedure w/a
five Fr AS, PSC
from an earlier
PCI/CA, bleeding
disorder or
medical exclusion
by MD, use of
anticoagulant
therapy with an
INR >/= two, or
incapable of
making decisions,
inability to
comprehend
instructions, or
inability to walk.

Study Design/Protocol
Methods/Variables/
Measures/Instruments
-Prospective nonrandomized comparative
study w/cluster
allocation.
-Pretreatment w/Aspirin
(80/100mg). 100 IU
heparin/kg & PCI > 60
mins received 2,500 IU.
RN removed AS w/15
mins of manual
hemostatis for 15 mins
for an ACT < 250 s.
Ambulation 200 meters
w/RN post-TIB. D/C
assessment w/study
blinded MDs.
IG: TIB for four hours (n
= 329) CG: TIB till
following morning
(n = 202)
Variables/ Measures:
TIB, time of ambulation,
& PSCs (hematomas,
bleeding, false
aneurysms, & AV fistula)
Instruments: Data:
Medical/nursing notes
Bleeding: Manual
compression or > TIB
Hematoma: > five cms
False Aneurysm & AV
fistula: Dx by ultrasound
Statistical Analysis:
Descriptive & Chi-square
statistics (x2), Mann–
Whitney U test & t-tests

Results/
Main Findings

Implications/
Critique

Themes/
Comment

Baseline characteristics,
IG % vs. CG %:
Women 20.4 vs. 27.7,
p = 0.051
-Less women in early in IG.
-ACT in patients w/
complications was between
78-215 s.
PSC of IG # vs. CG #:
Hematoma: 5 vs. 2
Bleeding: 2 vs. 1
False aneurysm:
2 vs. 1
AV Fistula: 0 vs. 2
Total PSCs:
9 (2.7%) vs. 6 (3.0%).
-Non-inferiority testing
w/IG as non-inferior w/ 4%
as a one-sided test.
- Test for non-inferiority
shows that the IG’s
complication rate was not
increased from the control
group (p = 0.002).

-Early ambulation
at four vs. ten
hours post-PCI is
safe, but results
should be
interpreted
w/caution r/t
small number of
PSCs.
-The small PSCs
may be r/t
elective
procedures &
exclusion of
vascular
complication RFs.
-Change in
heparin protocol
ten weeks into the
study from a
standardized
dosage of
10,000 IU IV
heparin (less than
10% of
participants) at
the beginning of
study to 5,000 IU
if PCI > 60
mins.
-Weakness
include bias r/t to
no randomization,
changing the
heparin protocol,
LOE, & data from
one center.

-Early
ambulation at
four hours post
PCI may be
safe, but
caution should
be used r/t
underpowered
study, low-risk
patients used &
less women in
the early
ambulation
group.
-ACT levels
varied between
puncture site
complications
w/no pattern
for increased
risk if the
ACT was
higher.
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Tongsai, S., &
Thamlikitkul, V.
(2012). The safety
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International
Journal of
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4–1090. doi:
10.1016/j.ijnurstu.
2012.03.012

Primary
Objective:
To assess
safety and
risk of
major
vascular
complicatio
ns
(hematoma
and
bleeding)
in patients
undergoing
PCIs
during
early vs.
late
ambulation
postprocedure.
Secondary
Objective:
To assess if
early
ambulation
after PCIs
should be
implemente
d and no
further
primary
studies
should be
conducted.

CINAHL
COMPLETE

Study
Population/
Sample/Setting
-13,592 articles
yielded on adult
patients
undergoing access
femoral PCIs.
Three RCTs &
two quasiexperimental
studies (n= 1854)
Inclusion:
English language
quasi-randomized
& RCTs on
patient
undergoing PCI
who ambulated
early (two to four
hours) or later (six
to ten hours)
Exclusion: No
major vascular
complications &
duration of bed
rest > four hours
in both groups.
Databases:
MEDLINE,
PubMed, Web of
Science, The
Cochrane Library,
Embase, gray
literature, & handsearched relevant
studies

Study Design/Protocol
Methods/Variables/
Measures/Instruments
-Systematic literature
review & meta-analysis
Variables/Measures:
TIB & major vascular
complications (bleeding
& hematomas)
Intervention: Early
ambulation (two to four
hrs)
Control: Late ambulation
(six to ten hrs)
Instruments:
Bias: Funnel plot,
Egger’s test, Begg’s test,
& trim and fill method
Heterogeneity: Chisquare-based statistics
(x2), measures of
inconsistency (I 2), &
between study variances
(t2)
Effect size: RR
Outcomes: Forest plot,
pooled RR, & sensitivity
analysis

Results/
Main Findings

Implications/
Critique

Themes/
Comment

Bias: Minimal bias on
funnel plot for hematoma
events.
Hematoma events:
Egger’s test: p = 0.055
Begg’s test: p = 0.624
-Trim & fill unchanged for
hematoma events.
Bleeding events:
Egger’s test: p = 0.420
Begg’s test: p = 0.327
Heterogeneity:
Hematoma Events:
x2 =1.52, p = 0.823, I 2=0,
& τ2 < 0.0001
Bleeding Events:
x2 = 2.46, p = 0.652,
I2 = 0, & τ2 < 0.0001
Measures:
Hematoma events:
Pooled RR =0.82, 95%
CI: 0.53, 1.28, p = 0.38
Trim & Fill Estimate:
Pooled RR =0.74, 95%
CI:0.49, 1.12, p = 0.158
Bleeding Events:
Pooled RR =1.77,
95% CI:0.87, 3.59,
p = 0.117
-Influence analysis with no
major variation.

- DiCenso,
Guyatt, &
Ciliska’s (2005)
Meta-Analysis
Tool used, see
Appendix F.
- Assuming a
random effect
model, there is no
statistical
significance
difference
between early
ambulation (twofour hrs) vs. late
ambulation( sixten hrs), in
causing a vascular
event postfemoral PCI.
-Minor
publication bias
did not change
the author’s
conclusion (based
on trim & fill
method).
-Weakness
include small
number of studies
& a poorly
defined
population.

-Early
ambulation at
two- four hrs
vs. six-ten
hours does not
increase
vascular
complications.
-Data for
hematomas is
more precise.
-Strong metaanalysis r/t
rigorous
statistical
analysis,
despite
organization
and other
critical
appraisal
flaws.
-Could
elaborate more
on the results
of the
measures.
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C., McCosker, F.,
& Clearly, S.
(2008).
Comparison of
complications in
percutaneous
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407–413. doi:
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.7c.

Primary
objectives:
To explore
the
incidence
of groin
vascular
complicatio
ns in
patients
after a PCI
mobilized
at three,
four, & six
hours after
femoral
sheath
removal.

Reference ListAccessed via
PubMed

Study
Population/
Sample/Setting
-Patients
undergoing PCI
w/possible stents
at a tertiary
hospital in
Queensland,
Australia.
Inclusions:
Patients
undergoing PCIs
w/consent
(n = 306)
Exclusions:
Excessive
bleeding of the
groin puncture
site before AS
removal
w/manual
pressure needed
for hemostasis,
hematoma before
arterial sheath
removal,
hemostasis taking
longer > 30 mins,
non-compliant or
hypotensive
patients, &
patients unable to
walk.

Study Design/Protocol
Methods/Variables/
Measures/Instruments
-Quasi-experimental.
-Six or seven Fr AS
w/100 IU/kg of heparin
given during procedure.
AS pulled at an ACT of
170 ms w/10 mg IV
diazepam & 10mL 1%
lidocaine subQ around
the AS. Hemostatis was
achieved w/a
FemoStop™ over 30
mins. Study
randomization presented
to staff after hemostasis
w/a sealed envelope.
IGs: Three (n = 108) or
four (n = 100) hrs of bed
rest
CG: Six hrs bed rest
(n = 98)
Variables/Measures:
Ambulation time and
vascular complications
(hematomas & bleeding
after AS pull,
FemoStop™ removal;
before & after mobility;
& next morning).
Instruments:
Hematoma: > three cm
wide at groin site
Statistical Analysis:
Descriptive statistics.
Mann-Whitney U test, ttest, Bonferroni
correction, & analysis of
variance

Results/
Main Findings

Implications/Cri
tique

Themes/
Comment

IG (Three vs. Four hrs):
Baseline Characteristics:
Female # (%): 20 (18.5) vs.
22 (22)
Weight (kg): 86 vs. 83.2
Bleeding Post-mobility #
(%):
15 mins: 1 (0.9) vs. 1 (1)
60 mins: 1 (0.9) vs. 0
Hematomas Post-mobility
(#) %:
15 mins: 4 (3.7) vs. 5 (5)
60 min: 5 (4.6) vs. 5 (5)
Next day: 5 (4.6) vs. 8 (8)
CG: (Six hrs)
Baseline Characteristics:
Female(#) %: 13 (13.26 )
Weight (kg): 87.2
Bleeding Post-mobility:
none
Hematoma Post-mobility #
(%):
15 mins: 3 (3)
60 mins: 3 (3)
Next day: 7 (7.2)
Significant Group
Differences:
Four vs. Six hrs
Post-mobility Bleeding:
p = 0.047
Three vs. Six hrs
Post-mobility Hematoma:
p = 0.049

-There were some
statistically
significant
differences
between bleeding
at four vs. six hrs
and hematomas at
three vs. six hrs,
authors claimed
that no difference
based on
hypotheses tested.
-Although no data
was collected,
authors stated no
RPB, PAS, AV
fistulas, or overt
hemorrhage.
-Weaknesses of
study included
poor
representation of
women (despite
randomization),
one clinical site,
exclusion of 32
patients r/t
bleeding
complications
prior to AS
removal, &
methodological
weakness (lack of
study timeframe
& sample number
rationale).

-It may be safe
to ambulate
patients after
three hours of
bed rest after a
femoral access
PCI.
-There is no
difference
when
comparing
between all
three groups
in regards to
vascular
complications
after PCI.
-Safe
ambulation at
three hours
may reduce
cost.
-More
literature is
needed to
distinguish
patient RF for
vascular
complication
& early
ambulation.
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Hoffman, J. G.,
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Bartel, D. C.,
Slusser, J. P., &
Tilbury, R. T.
(2018). Decreased
bed rest postpercutaneous
coronary
intervention with
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Wiley & Sons,
Inc.), 27(1–2),
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80.

Primary
Objective:
Investigate
& compare
FAPS
complicatio
ns at four
hrs vs. six
hrs w/a
seven Fr
AS sheath
in patients
undergoing
a PCI
within the
NCDR/
CathPCI
database.
Other
Objectives
Compare
FAPS/other
complicatio
ns in EHR;
collect data
known to
increase
FAPS,; &
provide
ongoing
data &
ensure
positive
outcomes
for a
practice
change.

CINAHL
COMPLETE

Study
Population/
Sample/Setting
-All PCI
procedures w/a
seven Fr AS at a
large Midwestern
academic medical
center identified
by internal
database &
comparison to a
similar group in
NCDR.
Dates: Inclusion
was based on the
# in CS &
determining an
equal number in
the CG.
CS: May 20,
2013-December
31, 2014 (n=249)
CG: June 15,
2011-May 2013
(n=401).
Inclusion: 18+,
sheath removal on
unit Exclusion:
Protamine
administration
before AS
removal & six Fr
AS used

Study Design/Protocol
Methods/Variables/
Measures/Instruments
-Retrospective case study
-Trained RNs pulled AS
at bedside. First Two hrs:
supine & flat. Third hr:
HOB > 30 degrees or
turned on sheath side.
Fourth hr: Free to move
out of bed. Fifth/Sixth
hrs: CG patient
w/comfort bed position.
CS: Four hrs TIB
(n = 152)
CG Six hrs TIB
(n = 249)
Variables/Measures:
TIB, FAPS, ambulation
time, & other
complications in the
EHR.
Instruments:
Data : NCDR & EM.
NCDR: RBP; bleeding
w/in 72 hrs after PCI;
vascular access site
hematoma or bleed; Hgb
decrease by 3g/dl; blood
transfusion; or
procedure/surgery.
EHR: PA, AV fistula,
RPB, & external bleed
(bleeding/hematomas).
Statistical Analysis:
Two-sample t test,
Pearson chi-square test,
logistic regression, OR,
& adjusted associations

Results/
Main Findings

Implications/
Critique

Themes/
Comment

EHR Baseline
Characteristics:
Closure ACT: p < .001
Removal ACT: p <. 001
GPIIb/IIIa Inhibitors:
p = .005
Mean Age in years (SD):
71 (12.1) vs. 69.7 (12)
Male # (%): 112 (74) vs.
199 (80)
-Age, gender, & BMI not
significant. Multi-variable
modeling for hematomas,
ACT, & GP IIb/IIIa
inhibitors was not
significant.
EHR CS # (%) vs.
CG # (%):
Access Site Bleeding:
8 (5) vs. 9 (4), p = 0.43
Hematoma:
21 (14) vs. 25 (10),
p = 0.25
AV Fistula:
0 vs. 2 (1),
p = 0.27
-There were no RPB &
PSAs in either group.
NCDR (CS vs.CG):
Access site bleeding:
1(1) vs. 2(1), p = 0.87
Hematoma:
1 (1) vs. 2 (1), p = 0.87
Other bleeding:
2 (1) vs. 0, p = 0.07

-No statistically
significant
difference was
found between
CS & CG for
FAPS
complications
w/in the NCDR
or institution
EHR between
four vs. six hours
of bed rest postPCI.
-NCDR bleeding
rates w/in this
study comparable
to rates prior to
2013 bleeding
definition change.
-Institution
baseline
characteristic RF
(removal/ closure
ACT & use of GP
IIb/IIIa inhibitors)
data that was not
statistically
significantly w/a
multivariable
modeling.
-Weakness
include inability
to generalize
beyond study (r/t
underpowered
study), & low
LOE.

-There may be
no difference
in bleeding
rates between
four hours vs.
six hours of
bed rest after a
femoral PCI
using a seven
Fr AS.
-Difference in
definitions of
bleeding
complications/
FASCS
between the
NCDR & EHR
could show
how nursing
interventions
contribute to
quality of care
& overall
outcomes in a
PCI.
-First study to
use a larger
catheter than
five-six Fr AS.
-Would add to
nursing
literature
redesigned as a
RCT.
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Note. & = and; + = plus; % = percent; < = less than; > = greater than; # = number of; / = per; ACCF = American College of
Cardiology Foundation; ACS = acute coronary syndrome; ACT = activated clotting time; AGREE II = appraisal of guidelines for
research & evaluation; AHA = American Heart Association; aPTT = activated partial thrombin time; AS = arterial sheath; AV=
arteriovenous; CA = coronary angioplasty; BMI = body mass index; CAD = coronary artery disease; CC = cardiac catherization or
coronary angiogram; CG = control group; CHF = congestive heart failure; CI = confidence interval; cm = centimeter; COPD = chronic
obstructive pulmonary disease; CPGs = clinical practice guidelines; CPS = clinical practice standards; CS = case study; CV =
cardiovascular; DAPT = dual antiplatelet therapy; D/C = discharge; dx = diagnosis; EA = early ambulation; EHR= electronic health
record; FAPS = femoral arterial puncture site complications; Fr =French (arterial sheath); f/u = follow-up; G1= Group 1; G2 = Group
2; G3 = Group 3; GP IIb/IIa = glycoprotein IIb/IIIa inhibitors; H = heterogeneity; HDV = healthcare delivery values; Hgb =
hemoglobin; hrs = hours; ; HOB = head of bed; hx = history; IG = intervention group; INR = international normalized ratio; IU =
international units; IV = intravenous; kg = kilograms; LA = late ambulation; LOE = level of evidence; LMWH = low molecular
weight heparin; MD = medical doctor; mg = milligram; min = minutes; mL = milliliters; ms = milliseconds; NCDR = National
Cardiovascular Data Registry; NSTEMI = non-ST segment elevation myocardial infarction; OR = odds ratio; PAS =
pseudoaneurysms; PAD = peripheral arterial disease; PCI = percutaneous cardiac intervention; PCS = puncture site complications; pts
= patients; RCTs = randomized control trials; RF = risk factor; RNs = registered nurses; RPH = retroperitoneal hematoma; r/t = related
to; s = seconds; SCAI = Society for Cardiovascular Angiography and Interventions; SD = standard deviation; SDD = same-day
discharge; STEMI = ST segment elevation myocardial infarction; subQ = subcutaneous; TIB = time in bed; VCD = vascular closure
device; vs. = versus; w/ = with; Z = standard score.
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Appendix D
DiCenso, Guyatt and Ciliska’s (2005) Meta-Analysis Tool for Kim et al. (2013)
Questions to ask:
1. Are the results of the individual studies included similar across studies?
a. Yes, Figure 3 shows the results in odds ratio (OR) within the Mantel-Haenszel.
One outlier in the hematoma section (four versus six hours), and two within the
hemorrhage section.
2. Are the differences between studies truly differences or did the occur by chance?
a. Examine the extent to which the CIs of the individual studies overlap. The greater
the overlap, the more comfortable one can be in combining results.
i. There is overlap, more so in the hematoma vs. hemorrhage outcomes. For
hematoma, the confidence interval (CI) is 0.68 to 1.17, while the
hemorrhage data has a CI from 0.77 to 1.7. The results for the hematoma
data are more precise.
b. Examine whether the authors conducted statistical analysis of heterogeneity; the
degree of difference among study findings. The more significant the test (often
chi-square), (p-value < 0.50), the less likely the observed differences were due to
chance alone.
i. Both use the chi-square statistic only. For the hematoma data, p = 0.8003,
and for the hemorrhage data, the p = 0.7632. The test is set at p < 0.50,
which is standard. Since there is no significant heterogeneity, the authors
paired this together. However, there is no I2 statistic to assess the index of
heterogeneity. When self-calculated it was negative and thus can be
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considering 0% and indicates no heterogeneity. It would be nice for it to
be calculated for this study, but it was not.
3. Does the review address a sensible clinical question?
a. Yes, but no clinical question is asked, statements are made in the object in the
intro and methods section.
4. Does the review describe population, intervention/treatment, outcome(s) considered?
a. Population: post-femoral PCI (not implied in the beginning, but radial artery
access studies were excluded in the limitation section of the article).
b. Intervention: early ambulation. However, early ambulation was not defined till
after the search was complete. Early ambulation ranged from one-and-a half to six
hours.
c. Outcome: no difference between early and late ambulation in regards to bleeding
and hematomas.
5. Is the review question clearly stated?
a. No. A review question is not clearly stated.
Literature Review
6. Were comprehensive search methods used to locate studies?
a. Yes, this is explained in the methods section and in Figure 1, or the flow diagram
analysis. The characteristics of the studies were defined in Table 1.
7. Was a thorough search of appropriate databases done?
a. Yes, this is explained in the methods section and in Figure 1, or the flow diagram
analysis of the chart.
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8. Were other potentially important databases explored?
a. Only the databases listed were explored. No search of the reference lists or gray
literature.
9. Were the search methods clearly described?
a. Yes, much more clear than other sections within the paper.
10. Were conclusions drawn about the possible impact of publication bias?
a. Publication bias was addressed and the conclusion drawn was that there was no
publication bias using Macaskill’s test, regression analysis and a Funnel plot.
Macaskill’s test has a lower power than the alternative tests purposed. With low
power and likely a p-value of 0.05, there is a chance that a Type II error could be
made (not rejecting the null hypothesis in which there is no publication bias, when
in fact there could be publication bias).
11. Were the overall findings assessed for their robustness in terms of the selective
inclusion or exclusion of doubtful or biased studies?
a. It is unclear as three independent reviewers looked at the studies, but did not
include anything in the review of why articles were included or excluded based on
bias.
Study Selection
12. Were inclusion and exclusion criteria clearly described and fairly applied?
a. Yes, inclusion and exclusion were clearly described.
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Critical Appraisal of the Studies
13. Was study quality assessed by blinded or independent raters?
a. Yes, the study was assessed by three independent raters for all articles used in this
study.
14. Was the validity of included studies assessed?
a. Validity was not overtly addressed. Figure 1 addresses the process, and Table 1
and Table 2 state the characteristics of the studies. There is not a table addressing
the statistical validity of the studies. There are strict limiting conditions though
and all studies were reviewed by three independent reviewers.
15. Was the validity of studies assessed appropriately?
a. It is implied, but not overtly stated.
16. Are the validity criteria reported?
a. See Table 1, which tells why each one was included but does not address the
individual statistical results. No statistical analysis was a limiting factor per
authors.
17. Were the primary studies of high methodological quality?
a. Two studies were quasi-experimental, three were prospective randomized control
trials (RCTs), and 10 were RCTs.
Similarity of Groups, Treatments and Outcomes
18. Were reasons given for any differences between individual studies explored?
a. Yes, differences between studies was explored extensively. In Table 2, the
characteristics of different studies were discussed. In the discussion section there
was commentary regarding six of the 15 studies conducted prior to 2001. These
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studies had early ambulation at two-and-a-half to six hours, while studies
conducted after 2001, early ambulation ranged from one-and-a-half to four hours.
The authors acknowledged that this was a shorter time period and that the longer
period in earlier studies may have been due to lack of knowledge for optimal
ambulation time, as a standard had not been set.
b. Other differences addressed were the location of the studies (more studies outside
of North America were published later perhaps due to increased numbers of
deaths from the rising rates of cardiovascular disease), differences in the labeling
and measurement of hematomas and bleeding (only 10 studies mentioned the
differences in measurement), usage of certain drugs (high levels of antiplatelet
agents such as in the study by Höglund, Stenestrand, Tödt, & Johansson [2011]),
and very short ambulation times (Best et al., 2010).
c. A reasonable conclusion was drawn that one should “carefully consider the
difference in study subjects the sizes of the insertion tubes used, the usage of
antiplatelet and anticoagulation agents, and the methods of hemostasis at the
puncture site to avoid intercepting the study results too broadly.” (Kim et al.,
2013, p. 435). In the conclusion, Kim et al. (2013) reasonably stated to consider
the above factors, as well as the gender, and sizes of tubes placed in order to
accurately apply the results.
19. Are treatments similar enough to combine?
a. It does not appear so based on the differences listed in question 18 despite being
the same procedure. The test of heterogeneity at, p = .8003, and dp = .7632 do
not suggest this.
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b. The authors thought they were estimating the same effect and used the fixed
effect model. Since a fixed-effect model was used and this does not reflect the
true population, the authors suggest proceeding with caution when broadly
applying results in clinical practice.
20. Are the outcome measures similar between studies?
a. All the studies are quite similar, as indicated in Figure 3.
21. Do the included studies seem to indicate similar effects?
a. Yes, it indicates that early ambulation does not lead to increased bleeding and
hematomas at the puncture site.
22. If not, was the heterogeneity of effects assessed and discussed?
a. Non-applicable.
23. How precise were the results?
a. Since this is a fixed effect model with no heterogeneity, the results are precise, but
the data about hematoma results are more precise than the data regarding the data
about bleeding results.
Data Synthesis
24. Were the findings from individual studies combined appropriately?
a. Per the authors, they believed they were measuring the same thing, but did report
a degree of error in the measurements of hematomas differently and did not define
the degree of bleeding at the puncture site.
25. Are the methods to combine studies reported?
a. Yes, the methods to combine studies were reported.

68
26. Was the range of likely effect sizes presented?
a. Yes, in Figure 3.
27. How precise were the results?
a. Using the fixed-model, the results are precise. The results are more precise for
hematoma results vs. the bleeding results.
28. Were null findings interpreted carefully?
a. Yes, the null findings were discussed and interpreted carefully. The authors noted
that a fixed effects model was used and caution should be taken when assessing
results and applying them. The authors discuss that in theory, early ambulation
should work, but caution should be taken considering other factors.
29. Are review methods clearly reported?
a. For the most part yes, Table 2 could be revised to better display the results.
30. Application of results to Patient Care
a. Is a practice change warranted? Were all the important outcomes considered?
i. Yes, this is a high level of evidence study with a rigorous search method
and no statistical difference, despite the low count of studies. The authors
are reasonable when suggesting caution when applying the results.
b. Are the benefits worth the costs and potential risks?
i. Yes, early ambulation can benefit the patient if considering stated risk
factors by the authors are taken into consideration.
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Appendix E
DiCenso, Guyatt, and Ciliska’s (2005) Meta-Analysis Tool for Mohammady, Atoof, Sari,
and Zolfaghari (2013)
Questions to ask
1. Are the results of the individual studies included similar across studies?
a. Five studies were included with similarities of population, test, and outcomes.
However, limitations included differences in bed rest times, follow-up time (two48 hours) after practice, and other demographics were not recorded to evaluate
(gender, age, and type of medication used).
2. Are the differences between studies truly differences or did the occur by chance?
a. Examine the extent to which the confidence intervals of the individual studies
overlap. The greater the overlap, the more comfortable one can be in combining
results.
i. All of the outcomes overlapped except for the hematoma outcomes for
four-six hours vs. eight hours with the difference in in Figure 3. However,
there is a significant difference is in favor of the four-six hours as the
outcomes are to the left of the line. This is irrelevant as it is not the subject
that is being compared.
b. Examine whether the authors conducted statistical analysis of heterogeneity; the
degree of difference among study findings. The more significant the test, often
chi-square ( < .05), the less likely the observed differences were due to chance
alone.
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i. Assessing the Forest plots in Figure 3,4,5, and 6, the significant level is
set at, p < 0.10, in order to compensate for smaller sizes.
3. Does the review address a sensible clinical question?
a. The review answers a clinical statement, not a question. The clinical statement
addresses the difference in bed rest durations and how this can increase or
decrease vascular complications, and additionally how it affects back pain and
urinary problems.
4. Does the review describe population, intervention/treatment, outcome(s) considered?
a. Population: not clearly defined, but PCI participants are listed throughout the
study as included. In Appendix 1, the central search strategy used the term
transfemoral as opposed to femoral.
b. Intervention/treatment: bed rest timeframes.
c. Outcomes: hematoma, risk of bleeding, risk of pseudoaneurysm, and arterial
venous (AV) fistula.
5. Is the review question clearly stated?
a. There is no question, but a section with aims of assessing the outcomes.
Literature Review
6. Were comprehensive search methods used to locate studies?
a. Yes, the databases were listed, as well as the gray literature. However, one had to
search for this within the article as the comprehensive search methods were not
overtly stated.
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7. Was a thorough search of appropriate databases done?
a. Yes, a thorough search of appropriate databases was listed in Appendix 1 with the
mesh terms and general key terms used.
8. Were other potentially important databases explored?
a. The authors stated that the gray literature was searched, but the PRISMA flow
diagram in Figure 1 does not state the identify or where the other five studies
reviewed came from.
9. Were the search methods clearly described?
a. Yes, it was outlined in the Figure 1 and throughout the article.
10. Were conclusions drawn about the possible impact of publication bias?
a. Yes, the authors used the Cochrane Collaboration Tool for assessing the risk for
bias in included studies. It was ruled that the risk for bias was unclear for 80% of
the studies. There are no specific tools used to assess publication bias, but authors
did state there was a low risk for selective reporting or reporting bias in all five
studies.
11. Were the overall findings assessed for their robustness in terms of the selective inclusion
or exclusion of doubtful or biased studies?
a. Yes, the studies were assessed for selective inclusion and exclusion of doubtful or
biased studies.
Study Selection
12. Were inclusion and exclusion criteria clearly described and fairly applied?
a. Inclusion was easier to identify than exclusion within the study. One has to look
for the exclusions, but can be found with throughout the study.
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Critical Appraisal of the Studies
13. Was study quality assessed by blinded or independent raters?
a. Yes, two reviewers assessed the quality of each study, disagreements were
resolved by discussion, and data was extracted according to a structured format.
The Cochrane Collaboration Risk of Bias Assessment Tool was used to appraise
the acuity of the included studies.
14. Was the validity of included studies assessed?
a. No, the validity of the included studies was not well assessed. There is no
statistical analysis of the validity of the studies and the methodology of the studies
vary greatly.
15. Was the validity of studies assessed appropriately?
a. Likely not. A fixed effect method model was used, making one unable to apply
the results to the general population. To assess bias, the Cochrane Collaboration
Risk of Bias Assessment tool was used and reported bias for 80% of the studies.
16. Are the validity criteria reported?
a. There was an independent review by two reviewers to assess the quality of the
studies and disagreements resolved by discussion.
17. Were the primary studies of high methodological quality?
a. Yes, the studies were only randomized control trials (RCTs) and quasi-RCTs were
included in the meta-analysis.
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Similarity of Groups, Treatments and Outcomes
18. Were reasons given for any differences between individual studies explored?
a. Yes, it was discussed that hemostatis methods of the studies might make a
difference in the results (FemoStop™, manual pressure, but no vascular
compression devices).
19. Are treatments similar enough to combine?
a. Yes, tests of heterogeneity were used and did not show any differences as authors
were looking at the same population. However, it was acknowledged that
differences such as adjective therapies, gender, and age were missing and might
make a difference in the effect of the study.
20. Are the outcome measures similar between studies?
a. Yes, all studies had a control and experimental group.
21. Do the included studies seem to indicate similar effects?
a. Yes, the difference in bed rest is not statistically significantly. Some studies did
not look the same effects, make it difficult to compare outcomes such as AV
fistulas and pseudoaneurysms.
22. If not, was the heterogeneity of effects assessed and discussed?
a. Despite no statistical differences in heterogeneity of effects, authors discussed in
the discussion, limitations, and conclusion that there are differences in outcomes
studied, definitions of these outcomes, wide range of time periods, follow-up time
varying, assessing the difference in duration of bed rest by gender age, and types
of medication used.
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23. How precise were the results?
a. Hematoma and bleeding.
i. Two-four vs. six was more precise than three vs. 10.
b. For pseudoaneurysms results, there was only one per group and there was a widevariations, thus not as precise as the out types of vascular complications
i. For AV fistula, there were no events for the two-four vs. six-hour group
and thus could not be calculated.
Data Synthesis
24. Were the findings from individual studies combined appropriately?
a. Yes, the appropriately combined findings are listed in Table 1 (the general
characteristics of the included studies). In other words, the highest level of
evidence was chosen, but there were still some differences noted.
25. Are the methods to combine studies reported?
a. Yes, the Mantel-Haenszel fixed effect model was used with effect size of each
study in Figures 3,4,5, and 6.
26. Was the range of likely effect sizes presented?
a. Yes, but the range of likely effect sizes was scattered throughout Figures 3, 4,5,
and 6. There was no individual table for the effect size of each study, only a
discussion of general characteristics of included studies in Table 1.
27. How precise were the results?
a. The Forest plots in Figures 3,4,5, and 6 show overlap for all studies. The most
precise results were comparing two-four hours versus six hours in Figure 2, which
compared risk for hematoma at 0.89 (0.43-1.83).
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28. Were null findings interpreted carefully?
a.

The null findings were interpreted carefully, but there could be further discuss
regarding all the variable addressed and why hematomas had more precise results,
while bleeding, pseudoaneurysms, and AV fistulas did not.

29. Are review methods clearly reported?
a. Yes, review methods are clearly reported within the methods section.
Application of results to Patient Care
30. Is a practice change warranted? Were all the important outcomes considered? Are the
benefits worth the costs and potential risks?
a. Yes, I think a practice change would be warranted as it does address the many
vascular outcomes that can happen during a PCI. Despite the Forest plots in
Figure 5 and 6 favoring later ambulation, it should be noted that the
pseudoaneurysm and AV fistulas events are very small throughout all the studies
reviewed. I think the practice change would be safe, but the cost is unclear. The
practice change would benefit from being part of a larger RCT that analyzes
vascular outcomes in relation to risk factors and overall cost saving.
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Appendix F
DiCenso, Guyatt, and Ciliska’s (2005) Meta-Analysis Tool for Tongsai & Thamlikkul
(2012)
Questions to ask:
1. Are the results of the individual studies included similar across studies?
a. The effect size is listed on Table 2. No results from the individual studies were
statistically significant for a hematoma or a bleeding event, but the risk ratio (RR)
or the effect size varied by study.
2. Are the differences between studies truly differences or did the occur by chance?
a. Examine the extent to which the CIs of the individual studies overlap. The greater
the overlap, the more comfortable one can be in combining results.
i. Hematoma: all results overlap for the most part on the Forest plot in
Figure 3, but Augustin et al. (2010), reports a larger confidence interval
(CI), but with a sample size of two for that event, and thus this smaller
sample size can lead to a larger CI and less precision (0.06-16.14).
ii. Bleeding events: wider ranges of CIs, but they do overlap and lead to a
narrower pooled CI.
b. Examine whether the authors conducted statistical analysis of heterogeneity
(variation in study outcomes between the studies) the degree of difference among
study findings. The more significant the test (often chi-square), (<.05), the less
likely the observed differences were due to chance alone.
i. Hematoma
1. Hematoma events: x2 = 1.52, p = 0.823, I 2 = 0 & τ2 < 0.0001
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a. Hematoma events were not significant. Values of p < 0.10
or I2 > 50%, were needed per the study for the test to be
considered statistically significant. The p-value was not
significant, although the p-value can have a lower power
when the number of test is small. This was considered by
the authors and a higher significant level was taken here or
p < .10 and I 2 = 0. These results show no changes in
heterogeneity, or in other words it shows homogeneity (this
is a more comprehensive test that does not need the number
of studies and measures the percent of variation across
studies). Finally, the tau squared which is less than zero,
shows the observed variance is less than expected based on
the within study variance.
b. A random effects model was used first, perhaps due to the
fact that the authors assumed that the effect would not be
the same in all the studies (based on Table 2). This was
seen in Figure 3 & 4. Using the random effects model is
less powerful because p-values are larger and the CIs are
wider. However, the studies are a sample from a
population, and studies with varying effects may be truly
representative of the overall population. Fixed effect
models on the other hand assumes the effect is the same in
all studies, only using the sampling variation within the
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studies, it is more powerful and easier, no assumptions
though about representation.
2. Results were viewed from both random and fixed models, but first
a random effect model. The authors justified this by stating the
reasoning was for using the random effects model was due to the
author’s perception of the studies and their overall goals. Reasons
included: different independent studies from several difference
countries, and inferences based on random effects model can be
generalized beyond the studies included in the meta-analysis. Thus,
the studies can be pooled together to generate a single summary
result.
ii. Bleeding events
1. Bleeding events: x2 = 2.46, p = 0.652, I 2 = 0, & τ2 = < 0.0001
a. Bleeding events were not significant. The statistical
parameters for significance were p < 0.10 or I 2 > 50%. The
p-value was not significant (although the results can have a
lower power when the number of test is small, but this was
considered and higher significant level was taken here or
p < .10, the I 2 = 0 and shows no heterogeneity. Finally,
the tau squared which is less than zero, shows the observed
variance is less than expected based on the within study
variance. Thus, the studies can be pooled together to
generate a single summary result.
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3. Does the review address a sensible clinical question?
a. No clinical question is asked, but a clinical statement is posed in the abstract,
introduction, and conclusion. Yes, it addressed a clinical statement that cannot be
answered despite the supportive literature in regards to implications for patient
outcomes (pain, early ambulation, and comfort) and financial implications
(decrease length of stay and early discharge). The clinical question also asks if
any more primary studies need to be conducted.
4. Does the review describe population, intervention/treatment, outcome(s) considered?
a. Population: post-femoral access PCIs was not defined as easily, but is stated twice
that femoral procedures were part of the population studies, once in the
introduction and once in the discussion section. It is not included nor excluded in
either the inclusion and exclusion for the literature search. It is stated later on that
the population was focused on PCI through the femoral approach.
b. Intervention: clearly defined. Early ambulation at two-four hours and late
ambulation at six-ten hours. This is stated in the methods section, inclusion
section, and throughout the article.
c. Outcomes: no difference stated and the practice change should happen without
any more primary studies.
5. Is the review question clearly stated?
a. Review question not clearly defined, but a statement of why the meta-analysis is
being employed is stated as such, “Therefore, we performed a meta-analysis of
the existing data in order to determine if early ambulation is really safe in patients
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undergoing PCI and if it should be implemented without performing more
primary clinical studies” (Tongsai, & Thamlikitkul, 2012, p. 1085).
Literature Review
6. Were comprehensive search methods used to locate studies?
a. Yes, date, database location, key terms used, but the only thing was no limit on
timeframe, a reason was not given for this, but it ended up being from 2001 to
2011. It would have been helpful to include an appendix for clarity.
7. Was a thorough search of appropriate databases done?
a. Yes, large databases such as PubMed, Web of Science, Cochrane Library,
Embase, gray literature, and references lists were assessed for potential articles.
8. Were other potentially important databases explored?
a. Yes, the gray literature was also searched, along with each reference hand
searched.
9. Were the search methods clearly described?
a. Yes, a literature search with a flow diagram was provided. Inclusion and
exclusion were clearly laid out.
10. Were conclusions drawn about the possible impact of publication bias?
a. Yes, publication bias was addressed in a rigorous fashion. The funnel plot for
hematoma, Figure 2A, showed “minimal evidence of publication bias.” Both the
tests Egger’s & Begg’s test did not show there was no publication bias, but that
there was not significant publication bias present. Adjusting for publication bias
with the trim and fill method and did not change the pooled RR of bleeding. The
true estimate from Figure 2C for hematoma outcomes might be
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0.74 (95% CI: 0.49, 1.12, p = 0.158).
b. Even placing studies in a sensitivity analysis in Figure 5, did not have any large
effects for hematoma. Furthermore, the authors said including the gray literature
may have reduced potential publication bias and exclusion could have led to a
further asymmetrical funnel plot.
c. Authors acknowledged that adjustment for publication bias did not change the
conclusions of the study and stated that publication bias was unlikely to have
effect on the conclusions of the analysis.
d. Publication bias that can occur when studies with positive results (or significant
results) are more likely to be published than studies with negative or inclusive
results. Researchers may be reluctant to write up a paper for publication that has
non-significant results. Test for bias are usually underpowered and even nonsignificant results can actually have publication bias. Publication bias can be
affected by small studies as well.
e. Trim and fill method can be used to see what the effect would be like if no
publication bias was present.
11. Were the overall findings assessed for their robustness in terms of the selective inclusion or
exclusion of doubtful or biased studies?
a. Yes, the findings were deemed “robust” (p. 1085), by Tongsai and Thamlikitkul
(2012), due to their adjustments for publication bias after using the trim and fill
method and excluding publication bias. The authors deemed that only one study
minimally changed results for bleeding. There was no exclusion, but
acknowledgement of these the small changes these had on results.
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Study Selection
12. Were inclusion and exclusion criteria clearly described and fairly applied?
a. Yes. Inclusion and exclusion are stated in the literature search section and in the
flow diagram in Figure 1.
Critical Appraisal of the Studies
13. Was study quality assessed by blinded or independent raters?
a. No.
14. Was the validity of included studies assessed?
a. Yes, it was stated in the methods and result sections. It was summarized in the
flow diagram in Figure 1 and Table 2. The validity of the studies mainly revolves
around the statistical validity.
15. Was the validity of studies assessed appropriately?
a. Yes and no. Authors names who reviewed the data not given, how they decided
upon why the five articles were used. However, the inclusion criteria were strict
and may have only been able to include the timeframe criteria for the control and
intervention groups.
16. Are the validity criteria reported?
a. Yes, in the flow diagram and within the results section.
17. Were the primary studies of high methodological quality?
a. Yes, three were randomized control trials and two were quasi-experimental.
Authors stated that this within the limitation section.
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Similarity of Groups, Treatments and Outcomes
18. Were reasons given for any differences between individual studies explored?
a. The reason was mentioned, but not explored in-depth.
19. Are treatments similar enough to combine?
a. Yes, treatments were similar to combine by assessing the CIs and the
heterogeneity. Despite the differences in measurement which was stated, there
was over overlap and statistical measurement for similarities.
20. Are the outcome measures similar between studies?
a. The RR was for the most part similar, as seen in Table 2.
21. Do the included studies seem to indicate similar effects?
a. Yes, almost all studies indicated similar effects, not difference in early vs. late
ambulation.
22. If not, was the heterogeneity of effects assessed and discussed?
a. Yes, the heterogeneity was discussed and there was no difference and even a
higher p-value was used to account for the small number of studies.
23. How precise were the results?
a. The Forest plots in Figure 4 show overlap and for all the studies. The precision for
hematoma events was much less for hematoma events vs. bleeding events in
Figure 3 and 4. However, with little heterogeneity within the random effects
model, the results for bleeding events could be considered more precise.
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Data Synthesis
24. Were the findings from individual studies combined appropriately?
a. Yes, an effect size was calculated in Table 2 and the endpoints and similar control
vs. intervention group results were part of the inclusion criteria.

25. Are the methods to combine studies reported?
a. Yes, effect size was reported in Table 2 as a RR.
26. Was the range of likely effect sizes presented?
a. Yes, the likely effect size can be seen in Table 2 and in the Forest plots in Figure
3 and Figure 4.
27. How precise were the results?
a. The Forest plots in Figure 4 show overlap and for all the studies. The precision for
hematoma events was much less for hematoma events vs. bleeding events in
Figure 3 and 4. However, with little heterogeneity within the random effects
model, the results for bleeding events could be considered more precise.
28. Were null findings interpreted carefully?
a. Yes, the null findings were helpful in this situation, as the intervention should not
cause any bleeding.
29. Are review methods clearly reported?
a. Yes. Review methods and results are listed within the methods section.

87
Application of results to Patient Care
30. Is a practice change warranted? Were all the important outcomes considered? Are the
benefits worth the costs and potential risks?
a. Yes, I think a practice change would be warranted, especially since this is a high
level of evidence. I think that looking at all vascular changes would be further
warranted from a RCT from an inter-disciplinary perspective.
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Appendix G
BROUWERS ET AL.’S (2010) Agree II Tool for Levine et al. (2011)
PICO Question:
(P) In adult patients undergoing PCI with a femoral access, (I) does early ambulation at or less
than four hours post-procedure, (C) as compared to later ambulation greater than four hours, (O)
have any impact on a patient’s risk of vascular complications?
Grading Criteria:
High quality guidelines are 80% or greater in relation to the PICO question. Scoring 1 (strongly
disagree) to 7 (strongly agree).
Domain 1: Scope & Purpose
1. The overall objective(s) of the guideline is (are) specifically described. (5)
a. This guideline is used to help physicians/advanced care providers select the best
strategies for managing care of patients undergoing percutaneous cardiac
interventions (PCIs) patients, creating clinical decision support tools, performance
measures, quality improvement, and appropriate use criteria. Although this guideline
is thorough in specifically describing medical interventions, outcomes, and
pharmacology for the procedure and adjunctive therapies, it does not describe in
detail the cares of patient after the procedure in regards to time in bed (TIB), and
early ambulation, who relate to this research question. It was given a score of (5)
because it does address important elements to the success of early ambulation
(populations, comorbidities, and vascular closure devices).
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2. The health question(s) covered by the guideline is (are) specifically described. (3)
a. This is an extremely broad clinical guideline that looks at the history, evolution, further
research, and current practices with the best evidence for PCIs. Although it addresses
many important parts of the procedure in detail, especially regarding the usage of
adjunctive therapies to prevent restenosis, it does not address the PICO question or
provide any guidance to writing a facility policy on early ambulation post-femoral PCI. It
was given a score of (3), because it does address important elements to the success of
early ambulation (populations, comorbidities, and vascular closure devices).
3. The population (patients, public, etc.) to whom the guideline is meant to apply is specifically
described. (7)
a. The population is adult patients undergoing percutaneous coronary intervention within
the United States. Co-morbidities such as diabetes mellitus, chronic kidney disease, and
specific populations are addressed (women, elderly, diabetics, and cardiac allografts) are
addressed. The authors even considered that literature not published in North America,
may not reflect the drugs, different practice patterns, and patient populations and
relevance to target population into account during review.

Item:

1

2

3

Total

Appraiser

5

3

7

15

#1

Domain #1 Score: 67%
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Doman 2:Stakeholder Involvement
4. The guideline development group includes individuals from all relevant professional groups.
(3)
a. The guideline development only included physicians, however these physicians are
considered experts in their fields of interventional cardiology, generally cardiology,
critical care cardiology, cardiothoracic surgery, clinical trials, and health service research.
The professional groups of the American College of Cardiology Foundations, Society for
Cardiovascular Angiography and Interventions, and the American Heart Association had
physician representatives on the writing committee. This was given a score of (3) because
it did not include all stakeholders including patients, nurses, pharmacist, nursing aides,
family members, EKG technicians, echo technicians, & catherization lab technicians, all
which play a part in the PCI process.
5. The views and preferences of the target population (patients, public, etc.) have been sought.
(1)
a. The views of the public in the guidelines are not easy to find. The only mention of this
topic is in regards to “patient preference” to have a PCI or a coronary artery bypass graft
for significant coronary artery stenosis and unacceptable angina that cannot be given
guideline-directed medical therapy/medical therapy. It does not assess patient preference
in any other topics throughout the guideline.
6. The target users of the guideline are clearly defined. (5)
a. Several times healthcare providers or healthcare workers are used, but mainly the term
physician is used. It is clear that the guidelines are for a healthcare provider, but does not
define this in-depth.
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Item:

4

5

6

Total

Appraiser #1

2

1

5

8

Domain #2 Score: 27%
Domain 3: Rigor of Development
7. Systematic methods were used to search for evidence. (4)
a. A search of the literature with listed terms was conducted from November 2010August 2011. Inclusion criteria included studies, reviews, and other evidence conducted
on human subject and published in the English language. Key terms used were noted
within the methodology section. There was discussion on exclusion of articles from other
countries that did not pertain to the North American population, but this exclusion was
not laid out in detail. There were no key terms relating to early ambulation, time in bed,
or bed rest. Databases were not listed, but authors did state references could all articles
used could be found for easy use in PubMed. There was not an appendix with search
strategies. There would not be enough information to replicate a search.
8. The criteria for selecting the evidence are clearly described. (2)
a. The population is well-defined. Inclusion and exclusion are poorly defined. There are
879 references so it hard to tell if any relevant literature was excluded.
9. The strengths and limitations of the body of evidence are clearly described. (6)
a. The Class of Recommendations and Level of Evidence or CC/AHA Clinical Practice
Guideline Recommendation Classification System was used to evaluate all guidelines in
this review. It was given a score of (6) because it did not grade any specific
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recommendations to early ambulation or decreased bed rest, only independent variables
related to early ambulation were graded (populations, comorbidities, & vascular
compression devices).
10. The methods for formulating the recommendations are clearly described. (6)
a. As listed above, the Class of Recommendations and Level of Evidence or CC/AHA
Clinical Practice Guideline Recommendation Classification System was used to score the
evidence by expert physicians in the field as well as members from professional
organizations listed above into a task force. The task force and peer reviewers also listed
relationships within the industry (as well as how they pertain to this guideline) and tried
to avoid conflicts of interest were listed in Appendix 1 and 2. All guidelines were voted
on during meetings or conference calls, and had to have the confidence vote by the
writing committee and updates as changes occurred. The guidelines were also subject to a
pilot project and were made more accessible, shorter, and easy to use based on these
recommendations. This question was given a score of (6) because it did not grade any
specific recommendations to early ambulation or decreased bed rest, only independent
variables related to early ambulation were graded (populations, comorbidities, & vascular
compression devices).
11. The health benefits, side effects, and risks have been considered in formulating the
recommendations. (6)
a. The guidelines assess the health benefits, side effects, and risk in extensively and with
proper guidance with the Class of Recommendations and Level of Evidence or CC/AHA
Clinical Practice Guideline Recommendation Classification System. This question was
given a score of (6) because it did not grade any specific recommendations to early
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ambulation or decreased bed rest, only independent variables related to early ambulation
were graded (populations, comorbidities, and vascular compression devices).
12. There is an explicit link between the recommendations and the supporting evidence. (4)
a. The guidelines are based on many studies, but are organized by the procedure
timeframe. Post-procedural care items such as bed rest and early ambulation were not
easy to find.
13. The guideline has been externally reviewed by experts prior to its publication. (5)
a. The guideline had been reviewed by expert peer reviewers listed in Appendix 2, but
their credentials were not listed. Authors also stated that a pilot release of the guidelines
was assessed and modifications were made prior the final version. Guidelines were
reviewed by physicians only.
14. A procedure for updating the guideline is provided. (3)
a. It is acknowledged that the guideline will need future updates, but a procedure is not
stated, nor a timeframe is given.
Item:

7

8

9

10

11

12

13

14

Total

Appraiser

4

2

6

6

6

4

5

3

36

#1

Domain #3 Score: 58%
Domain 4: Clarity of Presentation
15. The recommendations are specific and unambiguous. (2)
a. The authors state that clinical judgement should be used when making decisions
alongside these guidelines. This question was given a score of (2) because it did not grade
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any specific recommendations to early ambulation or decreased bed rest, only
independent variables related to early ambulation were graded (populations,
comorbidities, and vascular compression devices).
16. The different options for management of the condition or health issue are clearly presented.
(3)
a. Different options and considerations for comorbidities and special populations were
taken. This question was given a score of (3) because it did not grade any specific
recommendations to early ambulation or decreased bed rest, only independent variables
related to early ambulation were graded (populations, comorbidities, and vascular
compression devices).
17. Key recommendations are easily identifiable. (3)
a. The recommendations for bed rest and early ambulation can only be surmised from
only independent variables related to early ambulation (populations, comorbidities, and
vascular compression devices). There are no specific recommendations within the postprocedural care section regarding ambulation, just on adjunctive therapies, cardiac rehab,
exercise testing, and return to work recommendations.
Item:

15

16

17

Total

Appraiser #1

2

3

3

8

Domain #4 Score: 28%
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Domain 5: Applicability
18. The guideline describes facilitators and barriers to its application. (3)
a. Barriers and facilitators are described throughout the guidelines, but it is not all in one
place, nor does it address the barriers and facilitators or early ambulation.
19. The guideline provides advice and/or tools on how the recommendations can be put into
practice. (3)
a. Guidelines address how advice/tools can be put into medical practice, but not nursing
practice. There are few algorithms and checklists that can be utilized in daily care.
20. The potential resource implications of applying the recommendations have been considered.
(5)
a. The authors discuss the procedure and acknowledge realistic obstacles including cost.
This question was given a score of (5) because it did not grade any specific
recommendations to early ambulation or decreased bed rest, only independent variables
related to early ambulation were graded (populations, comorbidities, and vascular
compression devices) .
21. The guideline presents monitoring and/or auditing criteria. (4)
a. Brief paragraphs regarding angiographic and procedural monitoring and clinical
success are addressed. This question was given a score of (4) because it did not grade any
specific recommendations to early ambulation or decreased bed rest, only independent
variables related to early ambulation were graded (populations, comorbidities, and
vascular compression devices).
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Item:

18

19

20

21

Total

Appraiser #1

3

3

5

4

15

Domain #5 Score: 46%
Domain 6. Editorial Independence
22. The views of the funding body have not influenced the content of the guideline. (7)
a. The task force banned anyone from writing or voting on items that they had
relationships with the industry or conflicts of inters with. This was given a (7) due to
measures taken to ensure ethical clinical guidelines.
23. Competing interests of guideline development group members have been recorded and
addressed. (7)
a. Appendix 1 and 2 lay out the conflicts of interest (relationship with industry, expert
witness, expert speaker, and personal research) and had a policy that members could not
vote or write on items. The voting items were recorded in the first and second
appendices.
Item:

22

23

Total

Appraiser #1

7

7

14

Domain #6 Score: 100%
Overall Guideline Assessment
1. Rate the overall quality of the guidelines
a. I would rate the overall quality of this guideline poor to fair in the context of the
PICO question. One has to dig for independent variables and key terms in order to
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answer the question. This is an important guideline for the procedure though, and
recommendations for early ambulation and decreased TIB should be added for an
overall picture of the PCI process in future guideline recommendations for PCIs.
For this to happen, all healthcare providers and their tasks need to be taken into
consideration.
2. I would recommend these guidelines for use (yes, yes w/modifications, or no):
a. Yes, but with major modifications. The information is invaluable to the practice
and safety of a PCI, but would need further input for specific guidance of nursing
cares from both medical and nursing studies. Currently it only infers data from
populations, adjunctive therapies, and vascular compression devices and does not
make any claims on the proper time in bed and the safe amount of time prior to
ambulating.
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Appendix H
BROUWERS ET AL.’S (2010) AGREE II TOOL FOR ROLLEY ET
AL. (2011)
PICO Question:
(P) In adult patients undergoing PCI with a femoral access, (I) does early ambulation at or less
than four hours post-procedure, (C) as compared to later ambulation greater than four hours, (O)
have any impact on a patient’s risk of vascular complications?
Grading Criteria:
High quality guidelines are 80% or greater in relation to the PICO question. Scoring 1 (strongly
disagree) to 7 (strongly agree).
Domain 1: Scope & Purpose
1. The overall objective(s) of the guideline is (are) specifically described. (7)
a. The overall objectives are easily found and specific. These are nursing specific
clinical guidelines for the care of the percutaneous cardiac intervention (PCI)
patient. Specific guidelines that address the PICO question are addressed and
answered.
2. The health question(s) covered by the guideline is (are) specifically described. (6)
a. The health questions covered by the guidelines are not as easily found as the
objectives, however when found, if someone wanted to write a guideline
regarding this population on how to manage care before, during, and after a
percutaneous cardiac intervention (PCI), it would be easy to implement.
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3. The population (patients, public, etc.) to whom the guideline is meant to apply is
specifically described. (6)
a. The population is patients undergoing a PCI, special populations that may impact
outcomes include older age, women, anticoagulation therapy, repeat PCI
procedure, and arterial access site management. These populations are listed in
the introduction, but there is no special section on it and one has to dig through
the guidelines to find more specifics. The proper care of the special populations
would result, but it would benefit with special sections devoted to them, instead of
organizing in the procedural phase.
Item:

1

2

3

Total

Appraiser #1

7

6

6

19

Domain #1 Score: 94%
Doman 2:Stakeholder Involvement
4. The guideline development group includes individuals from all relevant professional groups.
(6)
a. These are nursing guidelines specific to PCI care with experts within the cardiac
nursing field. All authors are professors of nursing at colleges in Australia, New
Zealand, and the U.S. The question was given a score of (6), because important
issues of a nursing cares during a PCI is not only a nursing process and would
have benefited from other professional input (physician, advanced care providers,
catherization lab technicians, and others involved in the process).
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The term “expert interdisciplinary panel” (Rolley et al., 2011 p. 20) are used but
the term is not defined on who look at the final guidelines prior to submission for
publication.
5. The views and preferences of the target population (patients, public, etc.) have been sought.
(5)
a. The views of the cardiac nurses have been sought in an online survey and a
modified online Delphi Technique, and final input from “expert interdisciplinary
panel” (Rolley et al., 2011, p. 20) had been sought, but there is no discussion
regarding input from patients undergoing PCIs and their families.
6. The target users of the guideline are clearly defined. (7)
a. The target users of the population are nurses taking care of patients undergoing
PCIs. This is clearly stated in the title and throughout the document.
Item:

4

5

6

Total

Appraiser #1

6

5

7

18

Domain #2 Score: 83%

Domain 3: Rigor of Development
7. Systematic methods were used to search for evidence. (6)
a. The literature review was in a systemic review article titled “Review of nursing
care for patients undergoing percutaneous coronary intervention: a patient journey
approach” by the same authors with the intent of publishing these results as
clinical guidelines. Although databases, time periods, and search terms were
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listed, there was not clear audit trail of why articles were selected and some were
not. The authors broadly looked for guidelines related to acute coronary
syndrome, PCI, and secondary prevention, articles related to nursing cares of
patients undergoing a PCI, systematic review of studies, and patient care
guidelines using empirical methods. Reference lists of other articles and search
engines such as Google scholar were also used.
8. The criteria for selecting the evidence are clearly described. (6)
a. As listed from the article, “review of nursing care for patients undergoing
percutaneous coronary intervention: a patient journey approach” by Rolley et al.
(2009), three broad guidelines for a search strategy were given based on
interventional/descriptive studies describing nursing PCI cares, systematic
reviews of these studies, and patient care guidelines.
9. The strengths and limitations of the body of evidence are clearly described. (6)
a. The GRADE system for evidence and recommendations was used and described
within the guideline and system was used throughout all guideline
recommendations. Limitations of evidence are harder to find within the document.
In addition, there is ambiguous discussion regarding limitations within the
guidelines or the literature review article.
10. The methods for formulating the recommendations are clearly described. (7)
a. The GRADE system for evidence and recommendations was used and described
within the guideline and system was used throughout all guideline
recommendations.
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11. The health benefits, side effects, and risks have been considered in formulating the
recommendations. (6)
a. Harm is not discussed outright, but is implied through the guidelines graded and
the amount of evidence behind the GRADE scale.
12. There is an explicit link between the recommendations and the supporting evidence. (7)
a. All recommendations are supported by literature and graded by the quality of their
evidence by the type of study the evidence comes from.
13. The guideline has been externally reviewed by experts prior to its publication. (5)
a. The guidelines were reviewed by an outside inter-disciplinary group, but unsure if
there were any methodological experts within the group.
14. A procedure for updating the guideline is provided. (4)
a. It is acknowledged in the conclusion that this is the “first step” (Rolley et al.,
2011, p. 34), in establishing guidelines for cardiovascular nursing care of a PCI,
but there is not a procedure for updating, but acknowledgement that further
research is needed.
Item:

7

8

9

10

11

12

13

14

Total

Appraiser

6

6

6

7

6

7

5

4

47

#1

Domain #3 Score: 82%
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Domain 4: Clarity of Presentation
15. The recommendations are specific and unambiguous. (7)
a. The recommendations are specific to the population for which they apply.
16. The different options for management of the condition or health issue are clearly
presented.(6)
a. The different options for management of different condition or health issues are
present, but sometimes not well-organized.
17. Key recommendations are easily identifiable. (6)
a. Key recommendations are organized by part of the procedure, a lack of
knowledge would make it hard to find. Recommendations are grouped in boxes
within each section for ease of use.
Item:

15

16

17

Total

Appraiser #1

7

6

6

19

Domain #4 Score: 84%
Domain 5: Applicability
18. The guideline describes facilitators and barriers to its application. (7)
a. These are very specific guidelines for care and do acknowledge special
populations throughout the chapters and specially addresses early ambulation
caveats such as use of glycoprotein IIb/IIIa inhibitors and bivalirudin are
addressed.
19. The guideline provides advice and/or tools on how the recommendations can be put into
practice. (7)
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a. These guidelines address specific practice questions of nurses and could easily be
put into practice.
20. The potential resource implications of applying the recommendations have been considered.
a. Despite nursing time being considered a resource, the document does not address the
amount of time or cost of nurses ability to monitor for all these complications, cost
of medications, or cost of early ambulation, discharge, or complications cost.
21. The guideline presents monitoring and/or auditing criteria. (6)
a. The authors look to create nursing outcomes for the PCI process, but one has to assess
the whole document to find them and they are overall quite vague. In regards to vascular
complications, bleeding, hematoma, swelling, ecchymosis, and pseudo-aneurysms are all
addressed.
Item:

18

19

20

21

Total

Appraiser #1

7

7

3

6

23

Domain #5 Score: 79%
Domain 6. Editorial Independence
22. The views of the funding body have not influenced the content of the guideline. (7)
a. Conflict of interest was addressed after the conclusion. No conflicts of interest
were noted by any reviewers, participants, or researchers. It was acknowledged
that the research was supported by a grant and part of a PhD program of research.
It was also noted a research group called The Centre for Cardiovascular and
Chronic Care Research from the Curtin Health Innovation Research Institute of
Curtin University and the Australian Cardiovascular Nursing College provided
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administrative and technological support, but no financial support from either
entity was reported.
23. Competing interests of guideline development group members have been recorded and
addressed. (6)
a. Conflict of interest was denied and the organizations in # 22 involvement was noted,
but there was no list of who was related to the PhD program or the credentials of the
reviewers.
Item:

22

23

Total

Appraiser #1

6

6

12

Domain #6 Score: 83%
Overall Guideline Assessment
1. Rate the overall quality of the guidelines.
a. The overall quality of the guidelines is good. The guidelines address a gap in the
literature and provide excellent guidance to nursing cares of patients who are
undergoing a PCI that other guidelines lack. The guidelines would benefit from an
interdisciplinary approach.
2. I would recommend these guidelines for use (yes, yes w/modifications, or no):
a. Yes, with minor modifications. I would use these guidelines to help establish policy
and care of patients with PCIs, especially for post-procedural cares that address early
ambulation. I would supplement with other research in order to get a full picture
(input from the medical literature), but these guidelines are a good foundation to
establish specific nursing cares of a patient throughout a PCI
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